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ABSTRACT 
The three experiments described below offer support of immune function by the swine 
gastrointestinal epithelium.  Experiment one evaluated mediators that regulate the movement of 
macrophages (macrophage migration inhibitory factor; MIF), neutrophils (interleukin 8; IL8), 
dendritic cells (CC chemokine ligand 20; CCL20) and epithelial remodeling (osteopontin; OPN) 
in pigs challenged with Salmonella enterica serovar Typhimurium (ST) or Choleraesuis (SC).  
The proximal ileum had greater IL8 expression than the distal ileum (P < 0.05), and ST increased 
CCL20 (P < 0.05).  In vitro, MIF, IL8, CCL20 and OPN mRNA expression induced by 
lipopolysaccharide (LPS), ST or SC using pig jejunal epithelial cells (IPEC-J2) resulted in 
increased IL8 secretion, and increased IL8 and CCL20 mRNA by ST and SC (P < 0.05).  
Experiment two evaluated how Lactobacillus reuteri (LR) and Bacillus licheniformis (BL) 
differed from ST or SC in their ability to regulate, stimulate, or modify IL8, CCL20, and tumor 
necrosis factor α (TNFα) in IPEC-J2 cells.  ST stimulated an increase in IL8 secretion, with 
increases in IL8 mRNA (P < 0.05).  BL increased IL8 mRNA (P < 0.0001).  CCL20 mRNA was 
upregulated by ST (P < 0.05) and BL (P < 0.05).  Only ST increased TNFα mRNA (P < 0.05).   
Another objective evaluated whether pre-exposure of IPEC-J2 cells to LR or BL modified ST 
induced IL8 secretion.  IL8 secretion was increased by ST (P < 0.0001), and reduced by LR (P < 
0.05).   Only the BL/ST co-treated wells blunted basolateral IL8 secretion (P < 0.0001).  
Experiment three characterized the swine CCL20 mRNA sequence and evaluated tissue 
expression.  Cloning of CCL20 from the porcine jejunum predicted a 97 amino acid peptide.  All 
healthy tissues expressed CCL20 mRNA.  In animals challenged with Salmonella spp., SC 
increased spleen and liver CCL20 expression.  The data demonstrate that invasive bacterial 
pathogens in the pig gastrointestinal tract trigger upregulation of selected proinflammatory 
mediators; Salmonella spp. elicited differing patterns of activation in vitro and in vivo; IPEC-J2 
cells increased IL-8 secretion in response to ST and BL, but not LR, while ST stimulated 
secretion was inhibited basolaterally by BL pre-exposure; and numerous porcine tissues are 
prominent sources CCL20. 
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CHAPTER 1 - Literature Review: Summary of the intestinal 
mucosal immune system and microbial pathogenesis  
INTRODUCTION 
The aim of achieving a greater understanding to the fundamental mechanisms of bacterial 
pathogenesis and host immunity relates to the numerous bacterial infections that contribute to 
public health risks and economic losses.  Initially, the bacterial model systems investigating 
inflammation and infection in domestic livestock or laboratory animals were conducted utilizing 
bacterial lipopolysaccharide (LPS, the cell wall component of gram negative bacteria).  This 
model system results in strong proinflammatory responses in mice and swine, but at least in 
swine, LPS does not mimic the inflammatory response elicited by live enteric bacteria.  
Therefore a greater understanding of the mechanisms involved in live enteroinvasive bacterial 
pathogenesis is warranted.           
Traditionally, the gastrointestinal epithelial monolayer has been identified as the site of 
nutrient absorption which also provides physical barrier protection against luminal pathogens 
and toxins.  More recently, however, it has become well accepted that intestinal epithelial cells 
(IEC) are also active participants of the gastrointestinal immune system.  IEC are now regarded 
as participants of antigen presentation, and sources of both chemokine and cytokine mediators 
that assist in the gastrointestinal immune defense.  Therefore, IEC are a key intermediary in the 
crosstalk between the pathogen status of the gut lumen and underlying gastrointestinal immune 
tissues.    
Low dose dietary antibiotics, used as growth promotants, have been widely incorporated 
into livestock production since the 1950s, and the advantages for weanling pigs include 
improvement in average daily weight gain and feed efficiency.  However, such use of low dose 
dietary antibiotics has been questioned in recent years because of concerns that their use in 
livestock feed may lead to antibiotic resistant strains of pathogens that pose both a risk to 
livestock and (or) a public health risk.  Direct-fed microbials, including those containing 
Lactobacillus and Bacillus spp., are potential alternatives to low dose in-feed antibiotics.   
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The following literature review will focus on gut associated mucosal immunology and the 
role of gastrointestinal epithelial cells in the protection against enteropathogenic bacteria.  
Attention will also be given to the expression of various cytokine and chemokine mediators 
known to regulate the movement of macrophages (macrophage migration inhibitory factor; 
MIF), neutrophils (interleukin 8, IL8), dendritic cells (CC chemokine ligand 20, CCL20) and 
epithelial remodeling (osteopontin; OPN) and their role in conferring protection against bacterial 
invasion.  The final three chapters detail a series of in vitro and in vivo experiments providing 
new information on the response of swine and (or) isolated gastrointestinal epithelial cells to the 
invasive swine enteropathogens Salmonella enterica serovar Typhimurium (ST) or Choleraesuis 
(SC). 
ORGANIZATION OF THE INNATE INTESTINAL IMMUNE SYSTEM 
The intestinal epithelium represents the largest surface area of the body and performs 
multiple functions, which include those necessary for digestion, absorption and immune defense.  
The gastrointestinal tract (GIT) is home to roughly 500 to 1,000 species of bacteria with a 
biodiversity that includes Archaea, Eukarya, viruses, and bacteriophages, establishing a 
community of approximately 1012 resident microorganisms (Sonnenburg et al., 2004).  This 
makes GIT immune defense and host protection of utmost importance.  It is essential that the 
gastrointestinal system differentiate between pathogenic and commensal microbes in order to 
avoid over stimulation of the immune system yet maintain a disease free status.  The GIT  
provides barrier protection against commensal and pathogenic invaders, mediates crosstalk to 
more conventional immune cells, and is generally considered the host’s first line of defense 
against pathogenic microbes (Eckmann et al., 1995).  The intestinal immunological barrier is 
composed of the gut associated lymphoid tissue, and 25% of the intestinal mucosa is considered 
lymphoid tissue housing 70 to 80% of all immunogenic secreting cells (Langkamp-Henken et al., 
1992).  Immune cell compartments and cells associated with the gut mucosa include: villus and 
crypt intestinal epithelial cells, paneth cells, the follicle associated epithelium (FAE) overlying 
the Peyer’s patches (PP) including both intestinal epithelial cells (IEC) and specialized epithelial 
microfold (M) cells; there is also the isolated lymphoid tissue, mesenteric lymph nodes (MLN), 
and the lamina propria (LP) which contains intraepithelial lymphocytes (IEL) including T and B 
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lymphocytes, monocytes, and dendritic cells (Brandtzaeg and Pabst, 2004; Dotan and Mayer, 
2003; Kagnoff, 1993; Muller et al., 2005).   
These mucosal associated immune components assist in both the innate and adaptive 
immune responses.  The function of the innate immune system is to quickly identify and respond 
to foreign microorganisms, to incapacitate pathogens, and act as an adjuvant for the acquired 
immune system (Yuan and Walker, 2004).  Essential components of the intestinal innate immune 
system include the epithelial cell monolayer (a mechanical barrier), secretory IgA, antimicrobial 
peptides and proteins, commensal intestinal microbes, and biochemicals such as gastric acid, 
biliary and pancreatic secretions and mucins (Yuan and Walker, 2004).  Active antigen sampling 
occurs at the mucosal surface followed by delivery to the lymph node tissues, whereupon 
systemic immune activation occurs (Brandtzaeg and Pabst, 2004).  The M cells found in the FAE 
of the PP are considered the primary site of antigen sampling in the gut lumen, but both the villus 
epithelium and the PP of the small intestine are also participants of antigen sampling (Neutra et 
al., 1999).   
Generally, residents of the jejunal PP include populations of lymphocytes, dendritic cells, 
macrophages, villous epithelium, and the specialized follicle-associated epithelium, which along 
with M cells, are considered the main site of antigen uptake (Beier and Gebert, 1998). The 
jejunal PP within the pig populate both the jejunum and proximal ileum, are small, persist 
throughout life and number between 25 to 35 PP (Stokes et al., 1994).  The ileal PP in the pig is a 
large single ileocecal patch which extends along the terminal ileum (2.5 m in length) but 
involutes with age (Stokes et al., 1994).  T and B cell populations residing in each PP location 
vary with age and infection (Stokes et al., 1994).    
Gut associated participation in the innate immune response is mediated through pattern 
recognition receptors which are conserved germ line encoded receptors and molecules that 
recognize conserved pathogen associated molecular patterns.  Toll like receptors (TLRs) are one 
such pattern recognition receptor whose expression has been identified on intestinal epithelial 
cells (Abreu et al., 2003).  The function of these TLRs is to convert the gut recognition of 
pathogen associated molecular patterns into signals for enhanced immune function, including the 
increase in anti-microbial peptide expression, barrier fortification, and proliferation of epithelial 
cells (Abreu et al., 2005).  
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In addition to the TLRs, the intracellular receptor for endotoxin, nucleotide 
oligomerization domain (NOD) 1 and NOD 2, are also pattern recognition receptors which assist 
in monitoring the cytoplasm of cells for pathogen associated molecular patterns of invasive 
enteric pathogens (Abreu et al., 2005; Yuan and Walker, 2004).  Together with TLRs, NOD1 
(also known as CARD4; recognizing gram negative peptidoglycan) and NOD2 (CARD15; which 
recognizes both gram positive and negative peptidoglycan) contribute to the induction of the 
innate and acquired immune system (Collier-Hyams and Neish, 2005; Inohara et al., 2004).  
Aside from the above mentioned ligands, NOD1 and NOD2 also recognize specific motifs in 
bacterial LPS,  peptidoglycan, and bacterial muramyl dipeptide, which lead to the induction of 
proinflammatory mediators (Inohara et al., 2004; Eckmann, 2004).  TLRs and NOD proteins 
may act cooperatively in immune responses against bacteria.  MDP has been shown to synergize 
with LPS resulting in the production of cytokines, and the cross induction of signaling 
components needed by the NOD and TLR mediated pathways may account for the synergistic 
effect (Inohara et al., 2004).  For example, LPS up-regulates the expression of NOD2, and RICK, 
while MDP up-regulates MyD88, in TLR signaling (Inohara et al., 2004).  
Intestinal epithelial cells constitutively express NOD1 (Kim et al., 2004) and 
proinflammatory cytokines are produced in response to  peptidoglycan in gram-negative bacteria 
(Eckmann, 2004).  The signaling pathways involved in NOD1 and NOD2, and therefore the 
effects on pro-inflammatory cytokine production, include the caspase activation and recruitment 
domain which functions as an effecter domain and associates with RICK (a protein kinase) by a 
homophillic CARD-CARD interaction (Inohara and Nunez, 2003). RICK in turn activates IκB 
kinase and the transcription factor NFκB through the assembly of large multi-protein complexes 
as a result of oligomerization at the centrally located NOD domain (Girardin et al., 2003; Inohara 
and Nunez, 2003).  In various human colonic epithelial cell lines, bacterial pathogens (such as 
Escherichia coli, Salmonella enterica and Shigella flexneri) that bypassed the TLR activation 
pathway demonstrated activation of NFκB and NFκB target genes through NOD1 signaling, and 
therefore are a possible backup mechanism for activating the innate immune system during 
infection (Kim et al., 2004). In comparison, NOD2 is present in macrophages, dendritic and 
paneth cells, and are inducible in enterocytes (Eckmann, 2004).   
Peroxisome proliferator-activated receptors (PPARs) have also been identified as 
mediators in the control of gastrointestinal inflammation.   Specifically, PPARs are ligand 
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inducible transcription factors belonging to the nuclear hormone receptor family (Kostadinova et 
al., 2005).  Their anti-inflammatory action is mediated by: 1) the inhibition of pro-inflammatory 
cytokines, adhesion molecules and extracellular matrix proteins, 2) stimulation of anti-
inflammatory molecules, and 3) modulation of the proliferation, differentiation and survival of 
immune cells (including macrophages, B cells and T cells) (Kostadinova et al., 2005).  There are 
three isoforms of PPAR which include alpha, beta/delta, and gamma; and all three isoforms have 
been found in the GIT of humans and the rat (Wang et al., 2005).  Specifically, as determined by 
RT-PCR, the rat jejunum most abundantly expressed the alpha isoform, while the ileum 
expressed the beta form, and gamma was found in the duodenum, jejunum, cecum and colon; 
likewise, the human GIT ubiquitously expressed mRNA for all three isoforms along the entire 
tract (Bagga et al., 2003).  PPARγ is mainly expressed in epithelial cells, stellate cells, 
monocytes/macrophages, kupffer cells, dendritic cells, and B and T lymphocytes; with high 
levels documented in adipose tissue, large intestine (colon epithelium), and hematopoietic cells, 
followed by intermediate levels in the kidney, liver, stomach, small intestine, and pancreas 
(reviewed in Auwerx, 2002; Debril et al., 2001; Wu, 2003).  Natural ligands that are weak 
activators of PPARγ include polyunsaturated fatty acids, oxidized low density lipoprotein, some 
eicosanoids, and 15 deoxy-∆12,14-prostaglandin (PG)J2 (15d-PGJ2) (Wu, 2003).   The PPARγ 
has been associated with inflammatory bowel disease in that patients with ulcerative colitis have 
reduced levels of the gamma receptors, yet many studies on this topic seem to have produced 
contradictory results (reviewed in Wu, 2003).  Gastrointestinal inflammation may, in part, be 
mediated by the cyclopentenone prostanoid ligand, 15d-PGJ2; which leads to the reduced 
expression of the pro-inflammatory cytokine, IL8, by inhibition of NFκB via inhibition of IκBα 
degradation (Su et al., 1999).  This mechanism may assist in attenuating the ability of pathogenic 
microorganisms to cause damage to the GIT (Gupta et al., 2001). 
Intestinal epithelial and paneth cells also release gene encoded antibiotic peptides and 
proinflammatory cytokines that contribute to the innate immune response by blocking 
pathogenic microbes and microbial colonization.  Antimicrobial peptides found within the small 
intestine reside in paneth and epithelial cells that populate the crypts and include defensins, 
cathelicidins, bactericidal / permeability increasing protein, the chemokine macrophage 
inflammatory protein 3 alpha / CCL20, as well as the  bacteriolytic enzymes phospholipase A2 
and lysozyme (reviewed in Muller et al., 2005; Ouellette, 1999).  These peptides confer their 
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antimicrobial action through the formation of pores, activation of bacterial autolysins, disruption 
of outer and inner bacterial membranes, and degradation of bacterial lipids and peptidoglycan 
(Muller et al., 2005). 
Gastrointestinal defense against Salmonellosis 
In the United States an estimated 1.4 million persons are infected annually with 
Salmonella spp., a gram negative bacteria, which mostly results in a self-limiting diarrhea, 
vomiting, abdominal cramps, and fever, but also contributes to  approximately 15,000 
hospitalizations and roughly 500 deaths (Mead et al., 1999).  Among the poultry, swine, and 
feedlot cattle industries within the United States, 50% or more of the flocks and herds have been 
reported positive for Salmonella at various points within the production cycle (Hurd, 2004).  
Disease is usually seen with 108 to 1011 CFU of Salmonella via the oral route of infection and 
pigs can shed up to 106 CFU of SC or 107 CFU of ST per gram of feces (Fedorka-Cray et al., 
2000).  SC (as well as many other Salmonella spp.) has the ability to survive, remain viable and 
maintain infectivity for long periods in the environment (Gray and Fedorka-Cray, 2001).  Young 
pigs exposed to ST can be carriers for up to 28 wk after exposure (Wood et al., 1989) and sub-
clinically infected hosts increase the risk for infecting others and contaminating the food chain.  
A farm to fork mathematical model estimates the human health costs associated with 
salmonellosis in pork to be $81.53 million (90% confidence interval ranging from $18.75 to 
$197.44 million) (Miller et al., 2005).  Costs that account for human illness and lost production 
within the United States are estimated to be as high as 2.3 billion dollars annually (Hurd, 2004).  
Public health risks and economic losses associated with bacterial infections have led to 
the aim of understanding the mechanisms of bacterial pathogenesis and host immunity 
throughout the various stages of infection.  Initially, bacterial model systems that investigated 
inflammation and infection in domestic livestock or laboratory animals were conducted utilizing 
bacterial lipopolysaccharide (LPS, the cell wall component of gram negative bacteria), which 
initiated strong proinflammatory responses.  In pigs, this LPS model system produces rapid 
febrile responses; early transient increases followed by prolonged suppression in plasma levels of 
prostaglandin E2 (PGE2) (a pyrogenic mediator); reduced feed intake; and inactivity (Johnson 
and von Borell, 1994; Wright et al., 2000).  Peripherally administrated LPS in pigs also resulted 
in increased plasma proinflammatory cytokines (tumor necrosis factor α, (TNFα) and interleukin 
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1(IL1)), and plasma cortisol (an indicator of hypothalamic-pituitary-adrenal (HPA) axis 
activation); and reduced insulin-like growth factor (IGF-1) and increased growth hormone (GH) 
(two components of the somatotropic axis) (Webel et al., 1997; Wright et al., 2000). 
In contrast to the classical LPS model, administration of live Salmonellae via oral or 
intranasal routes has demonstrated a much different host response profile.  In pigs, a single oral 
dose of ST induced a strong febrile response, reduced feed intake, elevated plasma cortisol and 
reduced IGF-1; however, it did not affect plasma TNFα or PGE2 levels (evaluated over 5 d) 
(Balaji et al., 2000; Turner et al., 2002).  In germ free piglets, the systemic response to both 
nonvirulent and virulent strains of ST (evaluated after 24 h) resulted in an increased plasma 
IFNγ, but levels of TNFα, IL18 (induces IFNγ), IL1β, and IL10 were not different from control 
piglets (Splichal et al., 2002).  Localized within the ileum, however, the virulent ST strain 
(evaluated 24 h post exposure) significantly increased local IFNγ, TNFα, and IL1β (Splichal et 
al., 2002).  This is not to say that serum TNFα has not been reported in pigs exposed to 
Salmonella, but significant increases are generally seen in the weeks after challenge; such that 
intranasal challenge with 104 ST induced significant increases after 6 wk, and intranasal 
challenge with 106 ST increased TNFα during wk 2 to 4 post challenge (Stabel et al., 1995).    In 
that these data were collected from germ free pigs, they may not completely represent the natural 
gastrointestinal environment of pigs whose GIT have been colonized with commensal bacteria, 
yet the lack of a systemic cytokine response matches those of the weaned piglets previously 
described above, and suggests that ST induces a more localized immune response as opposed to 
the systemic LPS model.  
In vitro cultures of intestinal epithelial cells also differ in their responses after exposure to 
LPS, ST or SC which further suggests that LPS is not a completely accurate model of bacterial 
infection.  The swine jejunal epithelial cell line, IPEC-J2 (Rhoads et al., 1994) readily produced 
IL8, and increased the gene expression of IL8 and CCL20 after ST and to a much lesser extent 
SC exposure, but failed to respond to LPS (Skjolaas et al., 2006).  Several, but not all, human 
intestinal epithelial cell lines (which expressed low levels of TLR4) including Caco-2, T84, HT-
29, and differentiated HT-29/MTX have also demonstrated a similar pattern of 
hyporesponsiveness to LPS even in the presence of soluble CD14 and (or) LPS binding protein 
(Abreu et al., 2001; Bocker et al., 2003; Fierer et al., 1993), but when exposed to various 
pathogenic Salmonella strains, readily secreted several proinflammatory mediators including 
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PGE2, PGF2α, IL6, IL8 and CCL20 (Yang et al., 1997; Fierer et al., 1993; Stadnyk, 2002; 
Weinstein et al., 1997).  Comparing across numerous intestinal epithelial lines exposed to 
various Salmonella spp., several cytokines have been noted to increase in either gene expression 
or secretion profiles including those from the CXC chemokine classification (IL8, GROα, 
GROβ, GROγ, IP-10, Mig, I-TAC) the CC chemokines (MCP-1, MIP-1β, MIP-3α, RANTES) 
and cytokines (G-CSF, GM-CSF, IL6 and TNFα) (reviewed in Eckmann and Kagnoff, 2001).   
Salmonella spp. serve as a good model for studying bacterial pathogenesis, yet not all 
serovars of Salmonella elicit the same proinflammatory response in the host or within in vitro 
challenges.  For example, most clinical cases of salmonellosis in swine are caused by host 
adapted SC and non-host adapted ST, both of which are also human pathogens (Schwartz, 1999; 
Taylor, 1999).  The swine adapted SC is capable of causing systemic typhoid like disease and 
septicemia, while ST is not host adapted and the infection generally results in localized 
enterocolitis (Schwartz, 1999; Meyerholz et al., 2002).  Evaluation of immune gene expression 
from the MLN of 8 wk old pigs exposed to either ST or SC demonstrated a profile whereby SC 
induced a intense and extended up-regulation of immune genes, while ST exposure resulted in 
both a transient up-regulation of IFNγ, SOCS1, STAT1 and a down-regulation of IL4, IL6, IL1β, 
and TLR4 (Uthe et al., 2005).  The two strains also demonstrated differing patterns in pigs 
undergoing intranasal challenge in that ST increased TNFα in pigs several weeks after exposure, 
and an increase in TNFα was never observed in SC challenged pigs which exhibited clear signs 
of endotoxic shock (Stabel et al., 1995).  When investigating early invasion events, both ST and 
SC were able to invade the pig ileum without cell specificity as early as 10 min after inoculation; 
however, the two serovars demonstrated differences in M cell invasion, the formation of 
filopopodia and lamellipodia, and swelling patterns (Meyerholz and Stabel, 2003).  In addition, 
Meyerholz and Stabel, (2003) also observed that ST entered M cells in smaller numbers and SC 
induced more filopodia and lamellipodia but less swelling.  
The gut epithelium is not the only cell that mediates protection against Salmonellae 
infections.  Immune cells that play a key role in controlling and clearing Salmonella include 
monocytes/macrophages, neutrophils, and dendritic cells.  Cytokines released from monocytes 
and macrophages after exposure to Salmonella include those associated with inflammation (IL1, 
IL6, TNFα), chemoattraction (MIP1-α, MIP1-β, MIP-2), the induction of acute phase reactions, 
proliferation, and differentiation (IL6, GM-CSF, IL18, IL12p70); which  ultimately leads to the 
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further induction of both the innate and adaptive immune responses (reviewed in Eckmann and 
Kagnoff, 2001).   
Cytokines produced by animal models against Salmonella include the classical 
proinflammatory cytokines IL1 and TNFα, the “IFNγ axis” cytokines (IFNγ, and the IFNγ 
inducing cytokines IL12 and IL18), as well as the anti-inflammatory cytokines IL4 (lack of is 
protective) and IL10 (strongly increased); all of which aid in increasing survival (reviewed in 
Eckmann and Kagnoff, 2001).    
The involvement of probiotics in gastrointestinal immunity 
As mentioned above, the intestinal mucosa functions to serve as an active barrier in the 
defense against the continuous challenge of food antigens and pathogenic microorganisms which 
are continually entering the intestinal tract.  Aside from immune system protection, harmful 
agents are also cleared from the gut by the actions of gastric acid, peristalsis, mucus, intestinal 
proteolysis, and the intestinal biota (reviewed in Nava et al., 2005).  The hypothesis that 
beneficial bacterial communities in the gut lead to positive effects on host health has led to the 
development of therapeutics that are based on the consumption of beneficial bacterial cultures 
(Nava et al., 2005) that are marketed for both human and animal health benefits.  In addition to 
the above mentioned probiotics associated health benefit hypothesis, the use of probiotics in 
human and animal health has increased in recent years due to additional concerns about the 
failure to identify and generate new antibiotics, the impending ban on the use of low dose 
antibiotics as growth promotants in animal feed, and the emergence of pathogenic microbes with 
antibiotic resistance genes (Hong et al., 2005). The mechanisms by which probiotic bacteria 
could mediate changes in the GIT are not well understood.  However, Nava et al., (2005) 
suggested that probiotics may mediate their action by competing for intestinal epithelium 
adhesion receptors, and by the production of antibacterial substances (e.g., bacteriocins or 
colicins) which modulate immune responses.   
Bacterial spore formers, including those in the genus Bacillus, are one type of probiotic 
commonly seen in use today (Hong et al., 2005).   These probiotics are primarily used in their 
spore form, and have demonstrated beneficial effects in the prevention of gastrointestinal 
disorders (Hong et al., 2005).  Yet, interactions of Bacillus spp. in the gastrointestinal system are 
complex and not well understood.  Several studies have been completed with pigs using the 
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BioPlus® 2B supplement (containing Bacillus licheniformis and Bacillus subtilis spores) which 
contributed to improved sow and piglet performance (Alexopoulos et al., 2004).  Several 
Bacillus spp. have also been suggested to serve as a probiotic in broiler chickens.   Barbosa et al., 
(2005) isolated several Bacillus spp. from the chicken gut, and all strains examined demonstrated 
the ability to sporulate efficiently in the laboratory setting, to tolerated simulated gastrointestinal 
conditions, and to exhibit antimicrobial activity against a broad spectrum of bacteria, including: 
Clostridium perfringens, Staphylococcus aureus, and Listeria monocytogenes (Barbosa et al., 
2005).   
Lactic acid bacteria (LAB) are Gram positive bacteria with immunostimulatory properties 
(Meydani and Ha, 2000) that are also widely used as probiotics with reported health benefits 
against gastrointestinal disorders (diarrhea, inflammatory bowel disease, lactose intolerance, 
Salmonella or Shigella infections) (Goldin, 1998; Madsen et al., 2001).  The immunostimulatory 
effect of LAB are generally due to changes to the gastrointestinal microecology which can lead 
to stimulation of the gut associated lymphoid tissue resulting in cytokine and antibody 
production, phagocytic activity, and increased T cell and NK cell activity (reviewed in Meydani 
and Ha, 2000).  Among the LAB, Lactobacillus and Bifidobacterium are normal occupants of a 
healthy human intestinal microflora; however, not all LAB strains offer the same degree of 
immune function enhancement (Goldin, 1998; Meydani and Ha, 2000).   
Lactobacillus reuteri (LR) has been used in several studies to investigate its use as a 
probiotic.  Isolates of LR from pig feces have been proposed to be a strong probiotic choice in 
that LR has the ability to produce a broad spectrum antimicrobial compound (reuterin), which 
survives under gastrointestinal conditions (such as low pH) and has the capacity to colonize the 
intestinal tract (Rodriguez et al., 2003).   LR has also demonstrated direct anti-inflammatory 
activity in human epithelial cells when live (but not heat-killed, or gamma-irradiated) LR 
inhibited TNFα and ST induced IL8 expression and NFkB translocation in T84 and HT29 cells 
(Ma et al., 2004).  Oral ingestion of LR by healthy adult subjects also significantly increased 
CD4 T cell populations in the ileum which may assist in maintaining gut health (Valeur et al., 
2004). 
Two other mechanisms by which Lactobacillus spp. offer immune enhancement and host 
protection against infection with ST are via bactericidal activities as well as competition for 
attachment sites.  Examples of two intestinal isolates that offer such protection include 
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Lactobacillus reuteri JCM 1081 and Lactobacillus crispatus JCM 8779, both of which are highly 
adhesive to Caco-2 cells, are able to reduce adhesion of pathogenic Escherichia coli and ST, and 
offer bactericidal substances (Todoriki et al., 2001).  Lactobaillus rhamnosus also demonstrated 
increased host protection within BALB/c mice challenged with either a single oral dose or 
repeated daily doses (5 d) of ST, whereby probiotic fed mice exhibited higher health scores, 
higher serum and intestinal tract anti-Salmonella antibody titers, decreased pathogen burdens in 
visceral organs, and higher overall survival rates (Gill et al., 2001).  
The cellular and molecular mechanisms by which non-pathogenic bacteria directly 
influence the intestinal epithelium in order to limit the activation of the immune system are not 
fully understood.  Pre-exposure of intestinal epithelial cells lines (T84, HT-29, and HeLa) to an 
avirluent strain of Salmonella abrogated the wild type ST or TNFα stimulated production of 
inflammatory cytokines, which was a result of the stabilization of IκBα (Neish et al., 2000).  As 
mentioned earlier, pathogenic strains of bacteria activate the NFkB directed transcription of 
proinflammatory cytokines (Elewaut et al., 1999), but the avirulent Salmonella strain inhibited 
IκBα ubiquitination and degradation, thereby blocking NFkB translocation to the nucleus and 
gene activation (Neish et al., 2000).  Lactobacillus spp. also produces nonbacteriocin molecules 
whose actions have yet to be fully understood.    Cell free culture supernatants from 
Lactobacillus acidophilus have demonstrated that these non-lactic acid nonbacteriocin molecules 
have direct antagonistic activity on ST cells, which results in the rapid killing of ST via 
decreased intracellular ATP, increased membrane permeability with LPS release, and increased 
sensitivity to lytic enzymes (Coconnier-Polter et al., 2005).  Coconnier et al., (2000) also 
demonstrated that cell-free culture supernatants from Lactobacillus acidophilus could affect 
intracellular Salmonella residing in Caco-2 or TC7 cells, which included such effects as: 
decreased numbers of apical ST-induced F-actin rearrangements, decreased transcellular 
passage, inhibition of intracellular growth, and inhibited adhesion-dependent ST-induced IL8.   
Bacteroides thetaiotaomicron is also a common anaerobic resident of the human intestine 
which has been documented to participate in decreasing proinflammatory cytokine expression by 
modulating the NFkB and PPARγ pathways (Kelly et al., 2004).   Kelly et al., (2004) 
demonstrated that Caco-2 cells stimulated with S. enteritidis, E. coli, Phorbol myristate acetate 
(PMA), or flagellin enhanced nuclear translocation of the transcription factor NFkB subunit 
RelA to the nucleus, but when cells where co-incubated with the above mentioned stimulants and 
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B. thetaiotaomicron the NFkB subunit RelA was exported back out of the nucleus into the 
cytoplasm while other transcription factors (AP1, JunD) as well as phosphorylation and 
degradation of IkBα were not affected.  Likewise, PPARγ accumulates in the nucleus in Caco-2 
cells exposed to S. enteritidis, and co-culture with B. thetaiotaomicron also resulted in it is 
redistribution back to the cytosol, and the two events (NFkB, RelA, and PPARγ redistribution) 
appeared to be linked and essential for the nuclear export process (Kelly et al., 2004).    
Gastrointestinal epithelial cells induce cytokine / chemokine production 
Intestinal epithelial cells are considered prominent sources of chemokines and cytokines 
which lead to the recruitment of macrophages, lymphocytes, and polymorphonuclear leukocytes 
and can therefore further initiate both the innate and adaptive immune responses (Jung et al., 
1995; Maaser and Kagnoff, 2002).  Interestingly, it is the pathogenic bacteria, but not 
commensal, that are the trigger of such proinflammatory responses (Eckmann et al., 1997).  Jung 
et al., (1995) demonstrated that after challenge with invasive (but not non-invasive) bacterial 
strains, human colon epithelial cell lines (T84, HT29, and Caco-2) expressed the 
proinflammatory cytokines IL8, monocyte chemotactic protein –1 (MCP1), GM-CSF, and 
TNFα.  Cyclooxygenase-2 (a rate limiting enzyme for prostaglandin production) and NO 
synthase (controls NO production) are also upregulated after infection with invasive bacteria 
(reviewed in Elewaut et al., 1999).  The porcine intestinal epithelial cell line IPEC-J2 expresses 
mRNA for IL1α, IL6, IL7, IL8, IL12p40, IL18, TNFα, GM-CSF, CCL20, MIF, and OPN; and 
are also a prominent source of secreted IL8 (Schierack et al., 2005; Skjolaas et al., 2006).  The 
central regulator involved in the IEC response to enteroinvasive bacterial pathogens is the signal 
transduction pathway that includes Iκκ intermediates and the downstream activation of NFκB 
(Elewaut et al., 1999; Gewirtz et al., 2000).    
A closer look at selected chemokines/cytokines 
The modulation of gastrointestinal inflammation is multi-factorial as previously 
discussed.  Here we will look a bit more closely at the role of two chemokines and two cytokines 
which function as assistants in the protection and repair of the GIT.  
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Interleukin 8   
This cytokine is now classified as CXC chemokine ligand 8 (CXCL8) , and was first 
identified as a neutrophil activating factor (Thelen, 2001).  Receptors that IL8 is known to bind 
with high affinity include CXCR1 and CXCR2, (Holmes et al., 1991; Murphy, 1997).  Various 
types of bacteria have been shown to stimulate the release of IL8.  These bacteria include those 
that remain inside phagosomal vacuoles (Salmonella spp.) and those that enter the cytoplasm 
(Listeria monocytogenes) (Eckmann et al., 1993b).  However, not all bacteria or bacterial 
products elicit an IL8 response, for example, LPS or noninvasive bacteria including E. coli and 
Enteroccocus faecium were found to be unable to induced an IL8 response (Eckmann et al., 
1993b).  Functionally, IL8 is considered to have an important role in the initiation of 
inflammatory immune responses, and the induction of IL8 by inflammatory stimuli (e.g., LPS, 
TNFα or IL1β) aids in recruitment and activation of other immune cells (Harada et al., 1996; 
Miller and Krangel, 1992).  IL8 secreted from IEC may also be involved in mucosal healing as 
IL8 demonstrated colonic epithelial cell migration (Caco-2 and HT-29 cells) by CXCR1 
mediated pathways, without induction of cell proliferation (Sturm et al., 2005).  
In regards to IL8 produced from IEC, Eckmann et al., (1993b) have shown that epithelial 
cells from the intestine and cervix function to serve as an early signaling system to the host 
immune system by releasing IL8 after bacterial invasion.  The production of IL8 by polarized 
model intestinal epithelial lines in response to ST is predominantly toward the basolateral 
compartment and was observed to readily induce polymorphonuclear transepithelial migration 
(Eckmann et al., 1993a; McCormick et al., 1993).  This induction of IL8 secretion as a result of 
ST is mediated by increases in intracellular Ca2+ and the transcription factor NFκB (Gewirtz et 
al., 2000).   In conjunction with increased IL8 secretion, IL8 mRNA expression was also 
increased as soon as 60 minutes post S. dublin entry (Fierer et al., 1993).  IL8 mRNA expression 
increased in IPEC-J2 cells treated with ST or SC (108/well), but not LPS (5 ng/well) (Skjolaas et 
al., 2006), which is consistent with those observations taken from human gastrointestinal 
epithelial cell lines.  The predominantly basolateral secretion of IL8 has also been documented in 
the IPEC-J2 cell line post ST and SC exposure, but SC stimulated significantly less IL8 release 
(Schierack et al., 2005; Skjolaas et al., 2006).  The implication of IL8 within the GIT has further 
been noted in patients with the gastrointestinal inflammatory disorder, ulcerative colitis, who 
may have greater sensitivity to IL8 in that they demonstrated a strong upregulation in the 
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expression of CXCR1 receptors within colonic epithelial cells, which contrasts with normal 
mucosal tissues that demonstrate minimal expression of CXCR1 and no expression of CXCR2 
(Williams et al., 2000).    
CC chemokine ligand 20   
This chemokine is also termed macrophage inflammatory protein 3α (MIP3α) (Hieshima 
et al., 1997), or liver and activation regulated chemokine (LARC) (Hieshima et al., 1997), or 
Exudos-1 (Hromas et al., 1997).  Structurally, CCL20 is a 799 basepair sequence containing 4 
exons and three introns and encodes for a 96 amino acid protein (for an excellent review see 
Schutyser et al., 2003).  The functional and highly specific receptor for CCL20 is CCR6 (Baba et 
al., 1997; Liao et al., 1997).  Functionally, CCL20 is a chemoattractant for CD34+, CD11b+ 
immature myeloid derived dendritic cells (Iwasaki and Kelsall, 2000) and CD45RO+ memory T 
cells, both of which contribute to the adaptive immune response.  Although not all dendritic cells 
demonstrated the same migratory response to CCL20 in that murine lymphoid CD8αα dendritic 
cells that do not express CCR6 fail to migrate toward CCL20, and myeloid dendritic cells that 
reside in the spleen and express CCR6 also fail to migrate toward CCL20 (Iwasaki and Kelsall, 
2000).   
The expression of CCL20 has been documented within the normal human liver, lung, 
appendix, tonsil, lymph nodes, peripheral blood leukocytes, thymus, fetal liver, fetal lung, small 
intestine, colonic epithelial cells, stomach, bladder, pancreas, testis, cervical epithelial cells, 
placenta, and skin (reviewed in Schutyser et al., 2003).   Human cell types that express CCL20 in 
vitro include normal peripheral blood mononuclear cells (PBMCs), monocytes, macrophages, T 
lymphocytes, dendritic cells, neutrophils, mast cells, eosinophils, colonic epithelial cells, lower 
airway epithelial cells, keratinocytes, melanocytes, human umbilical vein endothelial cells 
(HUVEC), dermal microvascular endothelial cells, dermal fibroblast, and endometrial stromal 
cells (Schutyser et al., 2003) .  
Major expression of CCL20 has also been documented throughout the GIT, including the 
colon, small intestine, and appendix.   In vivo, inflamed tissue from the human colon was a 
major site of CCL20 mRNA expression; however, the normal colonic tissue maintains minimal 
CCL20 expression (Izadpanah et al., 2001).  In BALB/c mice CCL20 expression was 
constitutive in the colon and appendix and upon LPS stimulation this expression was reduced 
(Tanaka et al., 1999).  Yet, within the small intestine of BALB/c mice there was not a strong 
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constitutive expression of CCL20, but LPS stimulation was able to induce a  strong increase in 
the mRNA expression (Tanaka et al., 1999).  In contrast, C57BL/6 mice have shown constitutive 
expression of CCL20 in the small intestine; but it is important to note that regardless of these 
mice strain differences, it is widely accepted that the intestine, colon, and appendix appear to be 
major sites of CCL20 expression in mice (Tanaka et al., 1999).  
Therefore, it seems that CCL20 plays a predominant role in the GIT.  In vitro, several 
human IEC lines have been shown to express CCL20 mRNA and to produce the secreted CCL20 
protein, and both have been found to be increased post stimulation with either TNFα, IL1α, or 
exposure to Salmonella or E. coli (Izadpanah et al., 2001).  Various human IEC lines express 
constitutive (HT-29, Caco-2, LS174T, and I-407), and regulated (HT29 and Caco-2) expression 
of CCL20 mRNA levels (Izadpanah et al., 2001).  Polarized epithelial cells mainly secrete 
CCL20 protein in the basolateral direction, and functions through the NFkB target gene pathway 
(Fujiie et al., 2001; Izadpanah et al., 2001). Human IEC lines predominantly express CCR6 on 
the apical surface of polarized T84, Caco-2 and HCA-7 cell lines and CCL20 stimulation of the 
IEC CCR6 receptor results in tyrosine phosphorylation of the scaffolding adaptor protein 
p130cas, which is a key part of the cell migration focal adhesion kinase pathway (Yang et al., 
2005).  CCL20 was also able to reduce forskolin stimulated increases of cAMP levels and 
chloride secretion in T84, Caco-2 and HCA-7 cells; indicating CCL20 as a player in down 
regulation of ion secretion by IEC during bacterial infection and barrier compromise (Yang et al., 
2005).   
Macrophage migration inhibitory factor     
This cytokine is a 12.5 kDa, 115 amino acid protein, first discovered in 1966 as a T cell 
derived cytokine.  MIF was named for its ability to inhibit the random migration of macrophages 
in vitro, and is associated with the delayed type hypersensitivity response (reviewed in 
(Bernhagen et al., 1998; Bucala, 1996; Metz and Bucala, 1997; Nishihira, 1998).  The MIF gene 
is less than 1 kB and consists of three exons that are separated by two introns (Bernhagen et al., 
1998). Among the various species studied so far, it has been found that the rat, mouse, bovine, 
human, chicken, and porcine MIF all share close sequence homology (Abraham et al., 1998); 
(Nishihira, 1998).  
Physiological roles of MIF in vivo are not fully understood, but it is known that MIF can 
prevent the inhibitory effects of glucocorticoids, increase antibody production, activate T cells, 
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regulate insulin release from pancreatic β cells, activate the growth promotion signaling pathway 
ERK-1/2, and inhibit apoptosis (reviewed in Maaser and Kagnoff, 2002).  It has been suggested 
that MIF may serve a protective role in ST infections, such that MIF-/- mice challenged with ST 
failed to control the infection, failed to induce a protective Th1 response (as represented by 
serum IFNγ, IL12, and TNFα) and had higher levels of IL1β, NO, and corticosterone levels 
(Koebernick et al., 2002).  Caco-2 cells challenged with S. dublin have also been reported to 
increase MIF secretion, but not mRNA levels (which remained unchanged) and bacterial entry 
was confirmed to be the trigger for MIF release as noninvasive mutants of S. dublin did not show 
the same significant MIF release (Maaser et al., 2002).  In contrast, splenocytes isolated from 
young pigs and stimulated with concanavalin A upregulated the expression of MIF mRNA as 
compared to unstimulated splenocytes as determined by northern blot analysis (Skjolaas et al., 
2002). 
Maaser et al., (2002) have explored the expression and regulation of MIF in human 
intestinal tissue samples as well as the human IEC lines HT-29, LS174T, Caco-2, 1407, and 
HCA-7 to attempt to characterize MIF function in the gastrointestinal system.  Biologically 
active MIF (verified to arrest macrophage migration) was found to be expressed constitutively 
and at high levels both in vitro and in vivo.  Human IEC expression of MIF as determined by 
immunoblot analysis for protein expression from non-inflamed gastric, duodenal, and colon 
mucosa cell lysates, and mRNA expression from colon and gastric epithelial cells (amplified by 
reverse transcription PCR), all demonstrated strong expression (Maaser et al., 2002).  
Immunoblot analysis of confluent monolayers of Caco-2, HT-29, and T84 cell lines also 
demonstrated the same strong expression (Maaser et al., 2002).  The constitutive expression of 
MIF mRNA is also evident in IPEC-J2 cells, and MIF mRNA was not affected by treatments of 
LPS, ST, or SC (Skjolaas-Wilson et al., 2003).  The polarity of MIF secretion within IEC differs 
from that of other inflammatory associated cytokines such as IL8 and CCL20 in that MIF release 
was 70-80% into the apical direction of a transwell insert, and human colon lavage fluid also 
confirmed the apical release of MIF from epithelial cells (Maaser et al., 2002).   
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Osteopontin   
This cytokine is also known as early T lymphocyte activation 1 (Eta-1), was discovered 
in 1979, and is a 60 kDa protein of approximately 300 amino acid residues (Mazzali et al., 2002; 
O'Regan and Berman, 2000).  This protein has been found to be multifunctional and is expressed 
in many cell types including: bone, macrophages, endothelial cells, smooth muscle cells, and 
epithelial cells (Mazzali et al., 2002). Within the bone and at epithelial surfaces OPN is 
constitutively expressed, however, it can be upregulated in endothelial, smooth muscle, and 
inflammatory mononuclear cells (O'Regan and Berman, 2000).     
There is considerable variation in the forms of OPN due to alternate splicing, post-
translational phosphorylation and glycoslyated modification and has binding sequences for 
calcium, heparin, and arginine-glycine-aspartic acid (RGD sequence) (Mazzali et al., 2002; 
O'Regan and Berman, 2000).  OPN is also classified as an extracellular matrix protein due to the 
presence of the RGD sequence, which is known to be an integrin-binding motif.  The promoter 
contains motifs for a purine rich sequence, and ETS-like sequence, along with glucocorticoid and 
vitamin D response elements (Mazzali et al., 2002).  Receptors for OPN include integrins (that 
are RGD dependent) as well as the receptor CD44 (Weber et al., 2002).  OPN function is also 
controlled by cleavage at the RGD domain by thrombin (O'Regan and Berman, 2000). The C 
terminal domain of OPN interacting with CD44 induces macrophage chemotaxis whereas β3 
integrin receptors by interaction with the N terminal of OPN induces cell spreading and 
activation (Weber et al., 2002).   
The role of OPN in inflammation is that of a chemoattractant and inducer of T helper 
(Th) cells to secrete a panel of cytokines consistent with a Th1 response.  As a chemoattractant 
OPN has been documented to support adhesion of human and murine T cells and macrophages in 
vitro (O'Regan and Berman, 2000).  The accumulation of macrophages at sites of subcutaneous 
injection of OPN has been observed in vivo, along with high expression of OPN by macrophages 
post stimulation with N formyl methionyl leucyl phenylalanine (O'Regan and Berman, 2000).   
Th cells are a division of T lymphocytes identified as CD4+ cells that are MHC II 
restricted.  Th cells are divided into two functional groups classified as Th1 and Th2.  The Th 
subsets are believed to arise from a common precursor cell that becomes differentiated upon 
exposure to various factors (reviewed in Pellegrini et al., 2000).  As a modulator of cell mediated 
immunity, OPN has been shown to be an augmenting factor for the Th1 profiles.   Th1 cells 
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primarily secrete TNFβ, IL2 and IFNγ, and induce the classical cell mediated immune response 
aiding in the clearance of intracellular pathogens (Allen and Maizels, 1997).  IL12 secretion by 
activated monocytes, macrophages, and dendritic cells plays a critical role in the development of 
the Th1 response and cell-mediated immunity in that it causes the secretion of IFNγ from NK 
cells, and T cells, while enhancing the cytolytic functions of CD8+ T cells (Franchimont et al., 
2000).  NK cells and Th1 cells perpetuate the Th1 pathway by secreting IFNγ, which feeds back 
on macrophages and dendritic cells to increase IL-12 release, producing a positive feedback loop 
(Almawi et al., 1999).  On the other hand, Th2 cells secrete IL4, IL5, IL6, IL10, and IL13 and 
direct the immune system toward antibody production, providing help to the B lymphocytes, and 
assisting in the clearance of extracellular pathogens and parasites (Allen and Maizels, 1997; 
MacPhee et al., 2000).  Some factors that induce Th2 differentiation include: IL4, IL10, B cells 
as antigen presenting cells, a high dose of antigen, and the absence of cytotoxic T lymphocytes 
(reviewed by Fitch et al., 1993).  OPN has also been implicated in the increase of CD3 mediated 
T cell production of IFNγ (O'Regan et al., 2000).  In murine macrophages stimulated with LPS, 
OPN also directly induced production of IL12 while inhibiting IL10 expression thus suggesting a 
shift toward a Th1 profile (O'Regan et al., 2000).   However, OPN also increases CD40 ligand 
which augments T cell dependent IL12 production by human monocytes which may be the 
reason why OPN has the ability to also induce B cell proliferation and antibody production 
events (O'Regan et al., 2000).    
The GIT is also a site of prominent OPN expression.  Brown et al., (1992) demonstrated 
by immunohistochemical studies that OPN is prominently deposited at the luminal surfaces of 
epithelial cells including those associated with the GIT, gall bladder, pancreas, urinary and 
reproductive tracts, lung, breast, salivary glands, and sweat glands.  This group further suggested 
that epithelial secreted OPN binds to integrins on luminal surfaces and serves an important role 
in assisting in the communication between epithelial surfaces and the external environment 
(Brown et al., 1992).  Illeal samples taken from the normal human intestine and subjected to 
immuno-histochemistry also revealed expression of OPN protein within IEC, CD38 positive 
plasma cells, and macrophages from the lamina propria; with  complementary OPN mRNA 
expression in the IEC as well (Gassler et al., 2002). Within our laboratory, we have observed 
consistent expression of OPN mRNA by polarized IPEC-J2 cells, with increased expression after 
ST exposure (Skjolaas et al., 2006).   
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There appears to be an association between OPN and gastrointestinal health especially in 
regards to the generation of a Th1 cytokine profile.  In Crohn’s disease the local immune 
response tends toward the Th1 profile, and OPN has been associated with both normal and 
diseased GIT tissue (Gassler et al., 2002; Qu and Dvorak, 1997).  Relative to gastrointestinal 
disorders, the health status of the GIT seems to alter the normal pattern of OPN expression.  
Within actively inflamed ileal biopsies taken from Crohn’s disease patients a loss of IEC OPN 
protein and mRNA expression was observed with a corresponding increase in the density of GIT 
immune cells expressing OPN protein and mRNA (Gassler et al., 2002).  OPN is likely to also 
play a role in phagocytic and secretory cell functions in the health and disease states of the GIT.  
Tissue biopsies from patients with Crohn’s disease, Whipple’s disease and colitis have revealed 
OPN expression (as detected by immunogold labeling) in the duodenum, ileum, jejunum, and 
colon; and localized within lysosomes, mucigen granules, phagolysosomes, and golgi, of such 
cell types as macrophages, absorptive, mucous, Paneth, and epithelial cells (Qu and Dvorak, 
1997).   
SUMMARY AND CONCLUSIONS 
In regards to understanding the immune and inflammatory functions and regulation of the 
gastrointestinal epithelium in domestic farm animal species, there is still a great deal to be 
elucidated.  In light of the fact that a healthy gut mucosal epithelium is generally free of any 
ongoing inflammation, gaining a greater understanding of how this system protects against 
invading pathogens can assist in the understanding of the enteroinvasive 
pathogen/gastrointestinal disease state, or autoimmune diseases associated with imbalanced 
microbial populations.  Ongoing concerns about the generation of antibiotic resistant strains of 
bacteria as a result of the use of antibiotics as growth promotants in the livestock industry has 
facilitated a push for growth promotant alternatives.  The selection of future non-antibiotic 
candidate feed additives, such as probiotics or commensal bacteria, should offer a means by 
which bacterial adhesion and invasion is reduced thereby limiting the stimulation or over-
stimulation of the gastrointestinal immune system.  With an increased understanding of the 
physiology of the GIT, the development of potential feed additives or oral vaccine adjuvants 
could be generated that exploit M cell function, or TLRs, or enterocytes, or signaling pathways 
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involving PPARs and NOD, or take advantage epithelial chemokine or cytokine regulation to 
enhance growth or vaccine efficacy.  
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CHAPTER 2 - Effects of Salmonella enterica serovars Typhimurium 
(ST) and Choleraesuis (SC) on chemokine and cytokine expression 
in swine ileum and jejunal epithelial cells  
Reprinted from Veterinary Immunology and Immunopathology, 111, Skjolaas, K.A., Burkey, T. 
E., Dritz, S. S., Minton, J. E. Effects of Salmonella enterica serovars Typhimurium (ST) and 
Choleraesuis (SC) on chemokine and cytokine expression in swine ileum and jejunal epithelial 
cells. pp. 199-209. 2006. with permission from Elsevier. 
ABSTRACT 
The gastrointestinal epithelium represents a barrier to potentially invasive enteric 
pathogens, maintains a role in innate immune surveillance, and is a source of both chemokine 
and cytokine chemotactic mediators in response to bacterial invasion. In the current study, we 
evaluated cytokine and chemokine mediators known to regulate movement of macrophages 
(macrophage migration inhibitory factor; MIF), neutrophils (IL8), dendritic cells (CCL20) and 
epithelial remodeling (osteopontin; OPN) in response to invasive swine enteropathogens 
Salmonella enterica serovar Typhimurium (ST) or Choleraesuis (SC). For the in vivo 
experiment, weaned pigs served as uninfected controls (0 h) or were given 3 x 109 CFU ST 
orally. Pigs were sacrificed at 8, 24, 48, and 144 h after inoculation and total RNA was extracted 
from defined segments of proximal (PI) and distal (DI) ileum. Relative expression of MIF and 
OPN were not affected by ST. IL8 expression was increased numerically (P = 0.17 for the 
interaction term) at 24 and 144 h in the PI and these increases accounted for greater expression in 
the PI relative to the DI (P < 0.05). Relative expression of CCL20 was increased at 24 h after ST 
(P < 0.05). Next, we evaluated the time course of MIF, IL8, CCL20 and OPN mRNA expression 
induced by application of lipopolysaccharide (LPS), ST or SC in vitro using pig jejunal epithelial 
cells (IPEC-J2).  Cells were grown to confluency on permeable membranes, and treated apically 
with LPS (10 ng/ml), ST or SC (108/well). After 1 h, cells were washed to remove LPS or 
extracellular bacteria, and media containing gentamicin was added to kill remaining extracellular 
bacteria.  Media and RNA were collected at 1.5, 3, and 6 h after treatment.  MIF mRNA was not 
affected by LPS or bacterial treatment.  Similarly, IL8 expression was not affected by LPS, but 
was increased by ST and SC relative to controls at 1.5 and 3 h post exposure (P < 0.05 for all 
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comparisons).  Treatment with SC increased CCL20 mRNA relative to controls at 3 h (P < 0.05), 
while ST increased CCL20 at 1.5, 3 and 6 h with maximal expression at 6 h (P < 0.05 for all 
comparisons).   ST and SC increased polarized IL8 secretion.  Our data demonstrate that invasive 
bacterial pathogens in the pig gastrointestinal tract trigger upregulation of selected cytokine and 
chemokine mediators, but serovars of Salmonella elicited differing patterns of activation in vitro.  
 
1. INTRODUCTION 
A dynamic population of immune cells is maintained in the lamina propria in close 
association with the gastrointestinal epithelium in healthy pigs under production conditions. This 
population of cells is thought to be influenced by the commensal microbiota resulting in 
chemotactic signals that recruit and maintain appropriate cell types in the lamina propria. It has 
long been accepted that the presence of invasive enteric pathogens provokes increased migration 
of cells into the lamina propria and subepithelium, and salmonellae organisms are swine enteric 
pathogens that have long been associated with neutrophil infiltration into affected mucosal sites 
(Rothkotter et al., 1999). Although chemoattractive signals are undoubtedly emitted from sites 
colonized and penetrated by Salmonella spp., the time course of salmonellae-induced 
chemotactic signals in the pig gastrointestinal tract have not been thoroughly characterized. 
Microfold cells, the so-called M cells present in Peyer’s patches of gut associated 
lymphoid tissue, have been traditionally considered key in luminal antigen sampling, but their 
specific role in emitting cell trafficking signals is not known. However, there is now compelling 
evidence that enterocytes are key in generating chemotactic signals in response to enteric 
pathogens, including Salmonella enterica serovar Typhimurium (ST) (Eckmann et al., 1997). 
That enterocytes substantially outnumber M cells in the epithelium (Eckmann, Kagnoff 2001), 
even in Peyer’s patches (Gebert et al., 1996), suggests they could normally serve important roles 
in cell recruitment in response to salmonellae organisms. 
Here we report in vitro and in vivo experiments designed to determine dynamic changes 
in putative chemotactic signals in the pig gastrointestinal tract. Our working hypothesis was that 
the presence of an invasive bacterial pathogen would trigger upregulation of selected cytokine 
and chemokine mediators. We evaluated IL8 (also known as CXC chemokine ligand 8, CXCL8) 
as it is involved in neutrophil chemotaxis and is secreted by intestinal epithelial cells after 
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invasion by various bacteria (Eckmann et al., 1993b; Thelen 2001). CC chemokine ligand 20 
(CCL20), also termed macrophage inflammatory protein 3α (MIP3α) (Hieshima et al., 1997) was 
also evaluated as it is a chemoattractant for CD34+ immature dendritic cells and CD45RO+ 
memory T cells and was increased after stimulation with either TNFα, IL1α, or exposure to 
bacteria including Salmonella (Izadpanah et al., 2001). Finally, macrophage migration inhibitory 
factor (MIF) and osteopontin (OPN) were also evaluated as MIF is known to affect macrophage 
movement and was rapidly increased after Salmonella dublin challenge of Caco-2 cells (Maaser 
et al., 2002) and OPN is a key mediator of recruitment and retention of macrophages and T cells 
to sites of inflammation (Mazzali et al., 2002).   
 
2. MATERIALS AND METHODS 
2.1 In vivo challenge with Salmonella enterica serovar Typhimurium 
Twenty crossbred barrows, typical of commercial pigs and approximately 5 wk of age 
were used and the experimental protocol was approved by the Kansas State University 
Institutional Animal Care and Use Committee.  These pigs showed no clinical signs or laboratory 
evidence of salmonellosis or any other enteric diseases. Pigs were penned in an environmentally 
controlled isolation facility at 25°C and under constant light with ad libitum access to feed and 
water. After a period of 7 d in the facility, pigs were challenged orally with 3 x 109 CFU of ST or 
sterile medium (time 0 control). The ST was a primary isolate from a clinical case of 
salmonellosis in pigs and was confirmed to be ST at the National Veterinary Services 
Laboratory, Ames, IA, USA. Samples of the entire gut wall were obtained at two locations that 
included the continuous Peyer's patch. A sample containing the entire ileum was excised from 
the ileocecal fold back to the ileocolic junction and the digesta flushed with ice cold sterile 
phosphate buffered saline (PBS). Samples were obtained from the anterior and posterior ends of 
this excised, flushed segment and were labeled proximal ileum (PI) and distal ileum (DI), 
respectively. Gut samples were obtained at 0, 8, 24, 48, and 144 h after oral ST challenge (n = 
four pigs/sacrifice time). Tissue samples were placed in cold RNAlater® (Ambion, Inc.) until 
RNA extraction. 
 
2.2 Culture of jejunal epithelial cells 
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The neonatal jejunal epithelial cell line IPEC-J2 was derived from a single animal less 
than 12 h old (Rhoads et al., 1994).  These cells were a gift from Dr. Bruce Schultz, Anatomy 
and Physiology, Kansas State University. Cell growth was maintained on 50% DMEM - 50% 
F12 medium with fetal bovine serum (5%), insulin/ transferrin/ Na-selenite media supplement 
(1%), epidermal growth factor (5 ng/ml), and streptomycin/ penicillin (1%) (Invitrogen™ Life 
Technologies, cell culture products).  For experimentation, cells were seeded onto six-well 
Costar Snapwells (Corning Inc, Corning, NY) at 2.5 x 105 to 4.0 x 105 per well in a 0.5 ml 
volume and allowed to adhere for 24 h before being washed and re-fed every other day for 7 d of 
growth to allow for confluency and tight junction formation. In this in vitro system, average cell 
density was of 2.5 x 105 per well and transepithelial resistance typically was 4000 ohm*cm2.  
Twenty four hours before experimentation, the cells were washed and replacement media was as 
above but devoid of antibiotics. 
 
2.3 Bacteria for cell culture challenge  
Salmonella enterica serovars Typhimurium (ST) and Choleraesuis (SC) were from 
primary isolates from swine clinical cases (obtained from Dr. Jerome Nietfeld, Diagnostic 
Medicine/Pathobiology, Kansas State University). Identification of Salmonella serotypes was 
verified by National Veterinary Services Laboratory, Ames Iowa, USA.  Both strains were 
grown in Luria Bertani medium at 37°C, for 24 h, at which point bacterial populations were 
estimated by spectrophotometry at 600 nm optical density.  Bacteria was then pelleted and 
resuspended in DMEM/F12 growth media devoid of FBS and antibiotics. 
 
2.4 Exposure of jejunal epithelial cells to LPS and bacteria 
Treatments included control (uninfected cells), LPS (catalogue number L-6529 from E. 
coli 055:B5; Sigma Chemical Co., St. Louis, MO; 10 ng/ml), SC, and ST (both added at 1.0 x 
108 bacteria/well). Confluent IPEC-J2 cells, as described above, were washed twice with PBS 
and 0.5 ml of media alone (control), LPS, or bacteria were added to the top (apical) wells, while 
2.5 ml of media was added to the bottom (basolateral) wells and plates were further incubated at 
37°C, 5% CO2 for 1 h. Then, cells from all treatments were washed and both apical and 
basolateral media were replaced with fresh media containing 50 µg/ml gentamicin. Media were 
removed from both the apical and basolateral compartments at 1.5, 3, and 6 h after LPS or 
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bacteria exposure for determination of IL8 secretion (swine specific IL8 sandwich ELISA 
catalog KSC0181, Biosource International, Camarillo, CA USA), and cells were subjected to 
RNA extraction procedures.  This experiment was replicated three times with cells from two 
wells per treatment contributing data to each treatment x time mean.   
 
2.5 Real time PCR analysis  
Total RNA was extracted with TRI Reagent® (Sigma-Aldrich Co., St. Louis, MO) using 
the manufacturer’s protocol. Following total RNA isolation, the DNA-free™ (Ambion Inc., 
Austin, TX) kit was used to ensure removal of contaminating DNA from all RNA samples.  
Samples were frozen in 50 µl of nuclease-free water (Ambion Inc., Austin, TX).  RNA quality 
was verified by agarose gel electrophoresis and visualization of the 28S and 18S ribosomal 
RNA.  RNA quantity was determined by spectrophotometry using an optical density of 260 nm.  
Reverse transcription was carried out using TaqMan® reverse transcription reagents (Applied 
Biosystems, Foster City, CA). Briefly, reverse transcription was carried out in a 50 µl final 
volume that included 25 mM MgCl2, 500 µM dNTP’s, 2.5 µM random hexamers, 0.4 U/µl 
RNase inhibitor, 50 U/µl MultiScribe reverse transcriptase, and TaqMan RT buffer.  The reverse 
transcription mixture was incubated at 25°C for 10 min, heated to 37°C for 60 min, and 
inactivated at 95°C for 5 min.  The resultant cDNA was stored (-20°C) until used. Real-time 
quantitative PCR was utilized to quantify the products of interest (IL8, CCL20, MIF, and OPN) 
relative to the quantity of 18S rRNA in total RNA isolated from cultured IPEC-J2 cells and 
isolated porcine ileal samples.  The PCR reactions were carried out in 96-well plates with the 
appropriate forward and reverse primers (900nM), the appropriate TaqMan TAMRA probe (200 
nM), PCR Mastermix (Applied Biosystems, Foster City, CA), and 3.5 µl of the cDNA sample.  
The porcine specific cytokine primers and detection probes (Table 1) were synthesized from 
published GenBank sequences using Primer Express® software (Applied Biosystems, Foster 
City, CA).  Commercially available eukaryotic 18S rRNA (Applied Biosystems, Foster City, 
CA) primers and probe were used as an endogenous control.  Assays using non-template controls 
and samples were performed using the ABI Prism 7000 sequence detection system (Applied 
Biosystems, Foster City, CA).  Thermal cycling parameters were utilized according to 
manufacturer recommendations and included 50 cycles of 15 s at 95°C and 1 min at 60°C.   
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2.6 Statistical analyses 
Relative abundance of chemokines and cytokines in ileal samples were determined using 
the ∆∆CT method using the average pre-inoculation ∆CT (0 h) as the reference expression (n = 
tissue from four pigs at each time point). These ∆∆CT values were analyzed using the PROC 
MIXED procedure of SAS (SAS Inst. Inc., Cary, NC) with time, tissue location (PI and DI), and 
their interaction term (time*tissue) in the model. Real-time PCR data from cultured jejunal 
enterocytes were handled similarly except that ∆∆CT values were calculated relative to the 
average ∆CT of cells from control wells. Data bars in Figure 2 represent six observations per 
treatment obtained from duplicate wells of cells from three independent in vitro experiments. 
The model included effects of treatment, time and their interaction (treatment*hour). Polarized 
secretion of IL8 from cultured cells were analyzed with effects of treatment, time and location 
(apical or basolateral) in the model. Secretion of IL8 was expressed as pg/well to account for the 
considerably greater volume of media present in the basolateral compartment (2.5 ml) compared 
to the apical compartment (0.5 ml). 
 
3. RESULTS 
3.1 In vivo challenge with Salmonella enterica serovar Typhimurium 
This experiment was a time dependent study designed to evaluate the effect of oral ST 
challenge on MIF, IL8, CCL20, and OPN mRNA expression in ileal gut wall samples obtained 
from two distinct sites that contained the continuous Peyer’s patch (Figure 1). The expression of 
MIF did not change significantly in response to oral ST, although there was a modestly greater 
abundance of MIF in the DI (P < 0.05). There was a tendency for a time x tissue location 
interaction with respect to IL8 (P = 0.17) with numerically elevated expression at 24 and 144 h 
after ST of approximately 8- and 14-fold, respectively. These numeric increases in IL8 
contributed to significantly greater expression of IL8 in the PI (P < 0.05). For CCL20, there was 
a tendency for a time x tissue location interaction (P = 0.14) as CCL20 was increased about four-
fold at 24 h post-ST relative to time 0. This increase in CCL20 was largely accounted for by the 
increase in CCL20 expression in the PI. The expression of OPN was not affected by time post-
ST or ileal sampling location. 
 
 39
3.2 In vitro challenge of swine gut epithelium with LPS and Salmonella enterica serovars 
Typhimurium and Choleraesuis 
Because our evaluation of changes in selected cytokines and chemokines in the pig ileum 
after oral ST included cells within the entire width of the gut wall and not just the epithelial 
layer, we next sought to evaluate this same battery of chemoattractive mediators in 
gastrointestinal epithelial cells. We turned to an in vitro setting in subsequent experiments to 
specifically evaluate the responses of swine gut epithelial cells to direct bacterial challenge.  The 
IPEC-J2 cell line was used as a model gut epithelium to evaluate the effects of LPS, and two 
salmonella serovars ST, and SC on MIF, IL8, CCL20, and OPN mRNA expression (Figure 2) 
and polarized secretion of IL8 into the apical and basolateral media (Figure 3). 
Relative levels of MIF mRNA were not affected by either LPS or bacterial treatment. 
LPS did not affect IL8 mRNA, but IL8 mRNA was increased by about threefold at 1.5 h (Figure 
2B; P < 0.05) and about twofold at 3 h after SC (P < 0.05) relative to control. Similarly, IL8 
mRNA was increased by about threefold at both 1.5 and 3 h post ST relative to control wells 
(Figure 2B; P < 0.05 for both comparisons). Both salmonellae serovars affected expression of 
CCL20 relative to untreated wells (Figure 2C). Treatment with SC increased CCL20 mRNA by 
about 200-fold at 3 h (P < 0.05), whereas ST increased CCL20 by over 200-fold (P < 0.05), 600-
fold (P < 0.05), and about 150-fold (P < 0.05) at 1.5, 3, and 6 h, respectively. Only ST treatment 
affected OPN mRNA with just over a twofold increase relative to control wells at 6 h after 
bacterial treatment (Figure 2D; P < 0.05). 
Media from both the apical and basolateral compartments were collected at 1.5, 3.0 and 
6.0 h after treatment and the concentration of IL8 was determined using a swine-specific ELISA 
(Figure 3). The concentration in each compartment was adjusted to reflect the greater volume in 
the basolateral compartment and expressed as picograms/well. Treatment with ST increased IL8 
secretion in the basolateral direction (636.6 ± 132.0 pg/well; P < 0.05) above that of the control 
basolateral compartment (143.51 ± 132.0 pg/well) at 3 h. At 6 h post-ST, IL8 secretion was 
increased in both the apical (1592.0 ± 132.0 pg/well; P < 0.0001) and the basolateral (2975.2 ± 
132.0 pg/well; P < 0.0001) directions relative to controls (205.2 ± 132.0 pg/well apical and 123.9 
± 132.0 pg/well basolateral). At 6 h after treatment, ST-stimulated IL8 secretion was strongly, 
though not completely, polarized towards the basolateral compartment (apical, 1592.0 ± 132.0 
pg/well; basolateral, 2975.2 ± 132.0 pg/well; P < 0.0001). Treatment with SC stimulated IL8 
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secretion, but only after 6 h and only in the apical direction (546.6 ± 132.0 pg/well; P = 0.06) as 
compared to control (205.2 ± 132.0 pg/well). 
 
4. DISCUSSION 
Salmonella enterica serovar Typhimurium is an economically important swine 
enteropathogen and we have extensively characterized the pathophysiological consequences of 
oral challenge with this particular isolate, the same isolate used in the current studies. In earlier 
work, a single oral dose of ST produced transient enteric disease, including fever, inappetence, 
slowed growth (Balaji et al., 2000; Turner et al., 2002b; Turner et al., 2002a; Burkey et al., 
2004), activation of the endocrine stress axis (Balaji et al., 2000), and disruption of the endocrine 
growth axis (Balaji et al., 2000; Jenkins et al., 2004; Davis et al., 2005). Despite these 
unmistakable pathophysiologic changes, most of these effects resolved within approximately the 
first week following oral inoculation, and remarkably, these changes occurred completely in the 
absence of ST-induced elevations of systemic TNFα (Balaji et al., 2000; Fraser et al., 2005), 
IL1β (Fraser et al., 2005), or IL6 (Burkey et al., 2004). Collectively, these observations 
suggested to us that the inflammatory sequelae provoked by ST in the pig were effectively 
confined by the gut mucosal immune system. In the current experiments, we used this same 
swine model but focused on candidate molecules that could affect trafficking of immune cells 
into the subepithelial and lamina propria compartments in the pig gut mucosa in response to ST. 
Of many possible chemoattractant molecules, our initial focus was on a select group of 
cytokines and chemokines known to regulate movement of macrophages (MIF; Calandra, Roger 
2003; Lolis, Bucala 2003), chemotaxis of neutrophils (IL8; Eckmann et al., 1993b; Follin et al., 
1991; Fierer et al., 1993) trafficking of dendritic cells (CCL20; Dieu-Nosjean et al., 2000; Sierro 
et al., 2001), and epithelial remodeling in response to bacteria (OPN; Denhardt et al., 2001). We 
chose to evaluate expression of these inflammatory markers in defined locations within the 
ileum, without regard to the presence or absence of overt inflammation; as the pig ileum is 
reported to be a site for rapid epithelial invasion of ST (Meyerholz et al., 2002). 
In vivo, the expression of MIF and OPN in the current study was largely unaffected by 
ST through 144 h post-inoculation. However, based upon the Ct values from the real-time PCR 
assay for both of these cytokines (data not shown) both appeared to be expressed constitutively 
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at relatively high levels. Although MIF is a product of both epithelial cells (Arndt et al., 2002; 
Imamura et al., 1996; Maaser et al., 2002) and a variety of immune cells (Calandra et al., 1994; 
Calandra, Roger 2003), our previous studies in pig splenocyte cultures, presumably devoid of 
epithelial cells, indicated that MIF could not be detected by Northern blot analysis unless the 
cells were activated by mitogen (Skjolaas et al., 2002). Similarly, cells in our in vitro cultures of 
pig jejunal epithelial cells were also largely unresponsive to direct stimulation by 108 ST or SC. 
Yet, like the gut wall, these epithelial cells constitutively expressed high levels of both MIF and 
OPN (again based upon the Ct values in the real-time PCR assays), and this may suggest MIF 
and OPN expression in ileal gut wall samples may have been primarily from the epithelial layer. 
Taken together, our results, both in vivo and in vitro suggest neither MIF nor OPN are acutely 
regulated by ST in the pig small bowel wall. 
A statistically significant time post-ST or tissue by time interaction was not observed for 
IL8 mRNA in the pig ileum, and this precluded comparisons back to 0 h. Although relative 
expression of IL8 appeared to be increased at 24 and 48 h, the response at those times was highly 
variable among animals. There was a significant effect of location within the ileum, and we 
interpreted this effect to be accounted for by the high levels of IL8 expression at 24 and 48 h in 
the proximal ileum. At both times, those numerical elevations could be accounted for by 
relatively high fold changes by two of the animals at each time point. Salmonellosis in pigs has 
long been associated with neutrophilic invasion in the gut subepithelium (Grondahl et al., 1998; 
Lee et al., 2000; Lesser et al., 2000) and IL8 is a potent neutrophil chemoattractant (Eckmann et 
al., 1993b; Follin et al., 1991). However it is clear from our study that IL8 is not uniformly 
upregulated along the pig ileal gut wall following a single oral dose of ST, even though this 
bacterial challenge results in a host of pathophysiological sequelae (Balaji et al., 2000). Thus it 
seems likely that IL8 may be upregulated only in focal segments of gut actively contending with 
bacterial invasion and destined to be involved with recruitment of inflammatory cells. 
Similar to IL8, no tissue by time interaction was detected for CCL20, but there was a 
significant increase in CCL20 at 24 h after ST inoculation. It would appear that the majority of 
this increase was in the PI. The putative function of CCL20 in the pig ileum would be to recruit 
dendritic cells and perhaps T cells into inflamed gut wall (Izadpanah et al., 2001). However, like 
IL8, it is clear that CCL20 is upregulated transiently and not uniformly in the swine gut 
following a dose of ST that induces enteric disease in pigs. 
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It has become apparent within approximately the past decade that gastrointestinal 
epithelial cells not only serve a role in nutrient absorption, but also serve important functions in 
innate immune surveillance as well as provide a barrier to potentially invasive enteric pathogens. 
In terms of immune surveillance, considerable data have been gathered in model human 
epithelial systems utilizing a variety of cell lines. In general, these cell lines demonstrate 
transient upregulation of IL8 mRNA (Eckmann et al., 1993a; Eckmann et al., 1993b) and 
polarized secretion of IL8 favoring the basolateral direction (McCormick et al., 1993; Eckmann 
et al., 1993a). Our in vitro observations of both IL8 mRNA in response to SC and ST, and the 
highly polarized secretion of IL8, at least in response to ST (differences between the serovars 
discussed in more detail below), is consistent with published results from human cell lines and 
points to a role of the swine intestinal epithelium in recruiting neutrophils to focal areas of 
inflammatory damage.  
Like IL8, CCL20 too was upregulated by both SC and ST.  The response to SC was much 
diminished relative to ST which stimulated a several hundred fold increase in CCL20 relative 
expression by 3 h. Even so, the response to SC, though more short-lived, was not trivial as the 
bacteria stimulated CCL20 mRNA by over 200-fold.  These results follow the same trend as 
Caco-2 cells challenged with Salmonella Typhimurium ATCC14028 as reported by Sierro et al. 
(2001), whereby CCL20 mRNA expressed maximal transcription approximately 3 h after 
challenge.  However, IPEC-J2 cells seemed to have an increased magnitude of CCL20 mRNA 
expression following ST and SC challenge as compared to approximately a 27 fold increase in 
Caco-2 cells after ST challenge (Sierro et al., 2001). 
The lack of response of swine epithelial cells in vitro to LPS, both in terms of IL8 mRNA 
expression and secretion, is consistent with hyporesponsiveness observed in other model 
epithelial systems (Schuerer-Maly et al., 1994). The lack of response to LPS may have important 
physiological relevance in preventing unnecessary inflammatory responses to non-invasive 
bacteria or LPS that is normally present in the digesta at relatively high concentrations. 
Relative to the comparisons among the swine salmonellae servoars in our in vitro 
experiments, we were surprised to find ST generally more potent than SC in stimulating both IL8 
and CCL20 mRNA, and in stimulating IL8 secretion in swine epithelial cells. However, these 
observations may not be entirely unexpected for two reasons. First, SC is generally more likely 
to cause systemic disease in pigs than ST (Reed et al., 1986). So, in general, if SC has adopted 
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strategies that provoke reduced chemotactic responses from gut epithelial cells, this may provide 
the bacteria greater success in breaching epithelial barriers because it would generate a less 
robust innate immune response to epithelial detection. Or, secondly, it is possible that SC is less 
invasive to the intestinal epithelium and is more likely to gain infective access in field settings 
via oral or nasal epithelium.  Stabel et al. (1995) observed a much reduced TNFα response to 
intranasal SC compared to ST, and this led them to suggest that serovar differences in immune 
responsiveness in pigs may underlie pathogenicity.  In our IPEC-J2 in vitro setting, SC was able 
to induce an IL8 secretory response, however, as compared to ST, the response was less robust, 
occurred later (6 h post SC challenge) and only in the apical direction. This generally supports 
the hypothesis that SC may avoid provoking gut associated inflammatory signals and this may 
contribute to its host-adapted nature. 
For our in vitro salmonella culture experiments, 108 bacteria were added to the apical 
chamber of the model intestinal epithelium. Although this number of bacteria is commonly used 
for challenge of a variety of epithelial cell lines (Eckmann et al., 2000; Gewirtz et al., 2000; 
Sierro et al., 2001), the activation is designed to stimulate maximal chemokine responses from 
epithelial cells (Eckmann et al., 1997). In our system, this number equates roughly to 400 
bacteria per enterocyte, and it is difficult to accurately assess the physiological relevance of this 
bacterial load per unit area within the in vivo context of the swine small intestinal environment. 
However, what is clear from our in vivo studies is that, despite the variability among pigs, in 
individual animals in which ileal IL8 was upregulated, particularly at 144 h after oral 
inoculation, the magnitude of the upregulation exceeded that observed in vitro by several fold. 
This may indicate that, once breach of the epithelium occurs and inflammatory processes are 
initiated in focused regions of the gut, additional cell types within the gut wall are recruited for 
more sustained upregulation of IL8 than can be provided by the epithelium alone. 
In conclusion, we have shown that Salmonella serovars in the pig gastrointestinal tract 
triggered variable upregulation of IL8 and CCL20, with expression levels varying with either 
time and (or) location within the ileum.  In contrast, MIF and OPN were largely unaffected by 
Salmonella serovars either in the ileum or in vitro.  The use of a model swine gut epithelium also 
demonstrated changes in IL8 and CCL20 expression by enterocytes that was provoked by ST and 
SC, but ST appeared to elicit greater polarized secretion of IL8 and expression of CCL20.  These 
 44
differences may partially underlie differences in disease pathogenesis in swine between the two 
Salmonella serovars.   
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 Figure 2.1 Relative abundance of macrophage migration inhibitory factor (MIF; panel A 
time*tissue means; panel B tissue means), interleukin 8 (IL8; panel C  time*tissue means; 
panel D tissue means), macrophage inflammatory protein (MIP)3α/CC chemokine 
ligand-20 (CCL20; panel E time*tissue means; panel F time means), and osteopontin 
(OPN; panel G) mRNA from porcine proximal (PI) and distal ileum (DI) isolated at 0, 8, 
24, 48, and 144 h after 109 CFU oral Salmonella enterica serovar Typhimurium 
challenge. Each time*tissue bar in panels A, C, E, and G represents least square means of 
tissue obtained from four pigs at each time. 
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Figure 2.2 Relative abundance of macrophage migration inhibitory factor (MIF; panel A), 
interleukin 8 (IL8; panel B), macrophage inflammatory protein (MIP)3α/CC chemokine 
ligand-20 (CCL20; panel C) and osteopontin (OPN; panel D) mRNA from cultured 
porcine jejunal epithelial cells (IPEC-J2) treated with media alone (control), 10 ng/ml 
lipopolysaccharide (LPS), 108 CFU/well Salmonella enterica serovar Choleraesuis (SC), 
or 108 CFU/well Salmonella enterica serovar Typhimurium (ST).  Total RNA extracted at 
1.5, 3.0 and 6.0 h post treatment.  Each treatment*hour bar represents the least square 
mean (± SEM) of six observations. Asterisks denote significant differences between 
control and the treated wells.  
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Figure 2.3 Polarized interleukin 8 (IL8) secretion by confluent porcine jejunal epithelial cells 
(IPEC-J2) monolayers treated with media alone (control; CON), 5 ng/well (10 ng/ml) 
lipopolysaccharide (LPS), 108 CFU/well Salmonella enterica serovar Choleraesuis (SC), or 108 
CFU/well Typhimurium (ST) in the apical (AP) compartment for 1 h. Treatment media were 
removed and replaced with media containing gentamicin. Media from the AP and basolateral 
(BL) compartments were collected and assayed for cytokines at 1.5, 3.0, and 6.0 h after the onset 
of LPS or bacterial treatment. Each bar represents the least square mean (± SEM) of four 
observations. Significant accumulation of IL8 was observed at 6 h only in wells treated with ST, 
with greater secretion in the BL. 
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 Table 2.1 Primer and probe sequences used for cytokine and chemokine quantification by real-time RT-PCR 
 
Primer set Product 
length 
Forward primer sequence (5’-3’) Reverse primer  sequence (5’-3’) Probe sequence (5’-3’)1
Microphage migration 
inhibitory factor (MIF)       
75  ATG CCG ATG TTC GTG GTA AAC CTG AGT CAG CTC GGA GAG GAA TCC CCG CGC CTC TGT GCC 
Interleukin 8 (IL8)              73 GAG CTC TCC ATC CAG CAC AAG TCT CTT CCT GGC TCT GGT CCT A CCC CTG GGA CAG CAG AGC TCA CA 
Osteopontin (OPN) 81 CCC AAG GCC ATC CTC GTT ACT CGT CTC CTG ACT GTC CTT CTC  CAG CGC CTG CAC GTG GCT 
CCL20  76 GCT CCT GGC TGC TTT GAT G CAG TCA AAG TTG CTT GCT TCT GA CGG TGC TGC TCT ACC TCT GCA 
1All probes were synthesized with 6-FAM as the 5’ fluorophore and TAMRA as the 3’ quencher dye. 
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 CHAPTER 3 - Effects of Salmonella enterica serovar Typhimurium, 
or serovar Choleraesuis, Lactobacillus reuteri and Bacillus 
licheniformis on chemokine and cytokine expression in the swine 
jejunal epithelial cell line, IPEC-J2 
ABSTRACT 
Direct-fed microbials, including Lactobacillus and Bacillus spp., are potential 
replacements for low dose in-feed antibiotics for swine and other livestock.  To understand the 
function of these microbes in the gut, the current study used pig jejunal epithelial cells (IPEC-J2) 
to evaluate how Lactobacillus reuteri (LR) and Bacillus licheniformis (BL) differed from 
Salmonella enterica serovars Typhimurium (ST) or Choleraesuis (SC) in their ability to regulate, 
stimulate, or modify the proinflammatory mediators, interleukin 8 (IL8), CC chemokine 20 
(CCL20), and tumor necrosis factor α (TNFα).  To optimize the positive control to drive IL8 
secretion by IPEC-J2 cells, cells were treated apically with various concentrations of ST (vs. 
control (CTL)) for 1 h, followed by a wash.  Media containing gentamicin was added and 
collected at 6 h post treatment.  Compared to CTL, 108 ST produced maximal IL8 secretion in 
both the apical and basolateral directions, with significant basolateral polarization (P < 0.0001).  
We next evaluated the time course of IL8 secretion, and IL8, CCL20, and TNFα mRNA 
expression by IPEC-J2 cells treated apically with 108 ST, SC, LR, and BL vs. CTL.  Media and 
RNA were collected at 1.5, 3.0 and 6.0 h post treatment.  Only ST stimulated an increase in IL8 
secretion at any time point, with increases in IL8 mRNA at both 3 and 6 h (P < 0.05). However, 
BL increased IL8 mRNA at 1.5 h (P < 0.0001).  Neither LR nor SC affected IL8 mRNA 
expression.  CCL20 mRNA was strongly upregulated by ST (P < 0.05) and BL (1.5 and 3.0 h; P 
< 0.05), but not LR or SC.  Only ST increased TNFα mRNA relative to CTL (P < 0.05).  Two 
experiments were conducted to determine if pre-exposure of IPEC-J2 cells to LR or BL modified 
ST induced IL8 secretion. Confluent cells were treated apically overnight with various levels of 
LR or BL (in separate experiments) followed by ST challenge.  Media were collected at 4 (LR 
experiment) or 5 h (BL experiment) post ST.  In the LR study, IL8 secretion was increased by ST 
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as compared to CTL (P < 0.0001), reduced by LR (P < 0.05), and LR+ST co-treatments failed to 
alter ST stimulated secretion.  In the BL experiment, secretion of IL8 was increased by ST (P < 
0.0001), but blunted basolaterally in BL+ST co-treated wells.  The data demonstrate that IPEC-
J2 cells increase IL8 secretion in response to ST, and IL8 mRNA in response to ST and BL, but 
not LR. Furthermore, ST stimulated secretion of IL8 is inhibited basolaterally in the presence of 
BL. 
1. INTRODUCTION 
Low dose dietary antibiotics, used as growth promotants, have been widely incorporated 
into livestock production since the 1950s. The advantages of low-dose antimicrobials 
(particularly those included in diets for weanling pigs) have been well documented and include 
improvement in average daily weight gain and feed efficiency (Hays, 1978; Dritz et al., 2002; 
Gaskins et al., 2002; Zimmerman, 1986).  A definitive link between antibiotic use and gut 
pathogen load has not been established, yet several hypotheses and documented physiological, 
nutritional and metabolic effects on growth have been reported.  Some of these effects include: 
1) nutrient protection from microbial breakdown which increases their availability to the host, 2) 
thinning of the small intestinal barrier thereby allowing greater nutritional absorption, 3) 
decreased microbial toxins, 4) reduced sub-clinical intestinal infections, and 5) antimicrobial 
altered interactions between the gut and potential pathogens (Butaye et al., 2003; Gaskins et al., 
2002).  However, use of low dose dietary antibiotics has been questioned in recent years because 
of concerns that their use in  feed for the growth promotion of livestock may lead to strains of 
pathogens that are resistant to antibiotic therapy (Bach Knudsen, 2001).  Because of these 
concerns, there is an ongoing search for alternatives to the various antibiotics that are commonly 
used in livestock diets. Researchers have investigated many different natural alternatives 
including mineral supplements, acidifiers, botanicals, enzymes, and probiotics (Verstegen and 
Williams, 2002).   
Lactic acid bacteria are widely used as probiotics in humans with reported health benefits 
against gastrointestinal disorders including diarrhea, inflammatory bowel disease, lactose 
intolerance, and salmonella or shigella infections (Madsen, 2001).  Lactobacillus spp. are also 
found as probiotic applications in both companion and farm animal species.  Lactobacilli reuteri 
(LR) isolates from pig feces have been shown to produce a broad spectrum antimicrobial 
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compound (reuterin), and survive under low pH gastrointestinal conditions (Rodriguez et al., 
2003).  Rodriguez et al. (2003) also noted bile salt hydrolase activity which further confirmed the 
capacity of LR to colonize the intestinal tract, and suggests the benefit of LR as a probiotic.  LR 
has also demonstrated direct anti-inflammatory activity in human epithelial cells in that live, but 
not heat-killed, or gamma-irradiated LR was able to inhibit TNFα and Salmonella enterica 
serovar Typhimurium induced IL-8 secretion and NFκB translocation in T84 and HT29 cells 
(Ma et al., 2004).  Various Bacillus species are also in use as probiotic products for humans and 
animals (Hong et al., 2005), but their mechanism of action has yet to be fully understood.  
Several studies have been completed in pigs using the BioPlus® 2B supplement (containing 
Bacillus licheniformis and Bacillus subtilis spores), which demonstrated improved sow and 
piglet performance (Alexopoulos et al., 2004).   
Here we report in vitro experiments designed to determine dynamic changes in putative 
chemotactic and cytokine signals in the representative pig gastrointestinal epithelial cell line 
(IPEC-J2; Rhoads et al., 1994) after exposure to two pathogenic (Salmonella enterica serovar 
Typhimurium (ST) and Salmonella enterica serovar Choleraesuis (SC)), or two prototypical 
probiotic  bacterial strains which have been classified as probiotics (Lactobacillus reuteri (LR) 
and Bacillus licheniformis (BL)).  In addition, we evaluated how pretreatment of IPEC-J2 cells 
with the probiotic microbes (LR or BL) would affect ST mediated changes in the chemotactic 
signal, IL8.  Our working hypothesis was that the presence of invasive bacterial pathogens, but 
not the commensal microbes, would trigger upregulation of selected cytokine and chemokine 
mediators, and that pre-exposure of IPEC-J2 cells to LR and BL would downregulate the 
proinflammatory IL8 secretory response induced by ST.  We evaluated components of the 
epithelial inflammatory gene and protein network, including the chemokines IL8 (neutrophil 
attractant), and CC chemokine ligand CCL20 (CCL20, dendritic cell attractant), as well as the 
proinflammatory cytokine TNFα. 
2. MATERIALS AND METHODS 
2.1 Cell culture 
The neonatal jejunal epithelial cell line IPEC-J2 was derived from a single animal less 
than 12 h old (Rhoads et al., 1994).  These cells were a gift from Dr. Bruce Schultz, Department 
of Anatomy and Physiology, Kansas State University.  Cell growth was maintained on 50% 
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DMEM - 50% F12 medium (Invitrogen, Carlsbad, CA, USA) with 5% fetal bovine serum 
(Hyclone, Logan, UT, USA), 1% insulin/ transferrin/ Na Selenite media supplement (Sigma, St. 
Louis, MO, USA), 5 ng/ml epidermal growth factor (Invitrogen, Carlsbad, CA, USA) and 1% 
streptomycin/penicillin (Invitrogen, Carlsbad, CA, USA).  For experimentation cells were seeded 
onto 12 mm, six-well Costar Snapwells (Corning Inc, Corning, NY, USA) at 2.5 x 105 to 4.0 x 
105 per well in a 0.5 ml volume and allowed to adhere for 24 h before being washed and re-fed 
every other day to allow for confluency and tight junction formation.  Cells were used for 
experimentation within 14 d from seeding.  In this in vitro system, average cell density was 
based on hemacytometer counts of six individual trypsinized wells and was determined to be 
approximately 2.5 x 105 cells per well.  Transepithelial resistance was typically 4000 ohm cm2 
(which is comparable to findings by Schierack et al., 2005)).  Twenty four hours before 
experimentation, the cells were washed and replacement media was as above but devoid of 
antibiotics. 
 
2.2 Bacteria for cell culture challenge.   
Salmonella enterica serovars Typhimurium (ST) and Choleraesuis (SC) were primary 
isolates from swine clinical cases (obtained from Dr. Jerome Nietfeld, Associate Professor, 
Diagnostic Medicine / Pathobiology, Kansas State University Veterinary College).  Identification 
of Salmonella serotypes were verified by National Veterinary Services Laboratory, Ames, Iowa, 
USA.  Both salmonella strains were grown in Luria Bertani (LB) medium at 37°C, for 24 h, at 
which point bacterial populations were estimated by spectrophotometry at 600 nm optical 
density.  Lactobacillus reuteri (LR, ATCC no. 53608, swine intestine isolate) and Bacillus 
licheniformis (BL, Weigmann) Chester, ATCC no. 10716) were obtained from American Type 
Culture Collection (ATCC, Manassas, VA).  The LR bacterial strain was propagated overnight at 
37°C, 5% CO2 in Lactobacilli MRS broth, while BL was cultured in LB at 37°C.  Growth curves 
were established for both microbes and bacterial populations after overnight growth were 
estimated from the appropriate growth curve.  All bacteria were then individually pelleted and 
resuspended in DMEM/F12 growth media (but devoid of antibiotics) for use in IPEC-J2 
challenge. 
 
2.3 Salmonella enterica serovar Typhimurium induced IL8 upregulation in IPEC-J2 cells.  
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Treatments included control (uninfected cells), or ST at 104, 105, 106, 107, or 108 bacteria 
per well.  Confluent IPEC-J2 cells were as described above except that they were seeded into 24 
mm six-well Costar Transwells (Corning Inc, Corning, NY, USA) which allowed for a cell 
density of 1.5 x 106 cells per well after confluency.  Average cell density was based on 
hemacytometer counts of six individual trypsinized wells.  The application of 1.0 ml of media 
alone (control), or diluted bacteria were added to the top chamber, while 2.5 ml of media were 
added to the bottom chamber and plates were further incubated at 37°C, 5% CO2 for 1 h to allow 
bacterial entry.  After removal of the extracellular bacteria, the cultures were incubated for 6 h in 
the presence of 50 µg/ml of gentamicin (Gibco, Grand Island, NY, USA) to kill the remaining 
extracellular bacteria, and media were removed from both the apical and basolateral 
compartments for later IL8 cytokine secretion analysis. 
 
2.4 Exposure of IPEC-J2 cells to pathogenic or commensal bacteria  
Treatments included control (uninfected cells), SC, ST, LR, and BL (108 bacteria/well).  
Confluent IPEC-J2 cells, as described above for 12 mm Costar Snapwells, were washed twice 
with PBS and 0.5 ml of media alone (control), or diluted bacteria were added to the top chamber, 
while 2.5 ml of media were added to the bottom chamber and plates were further incubated at 
37°C, 5% CO2 for one hour to allow bacterial entry.  After removal of the extracellular bacteria, 
the cultures were incubated for 1.5, 3.0, and 6.0 h in the presence of 50 µg/ml of gentamicin 
(Gibco, Grand Island, NY).  At indicated times, media were removed from both the apical and 
basolateral compartments for later IL8 secretion (six replicates) and cells subjected to RNA 
extraction for later evaluation of chemokine or cytokine gene expression (three replicates). 
 
2.5 Overnight exposure of IPEC-J2 cells to Lactobacillus reuteri or Bacillus licheniformis 
followed by challenge with Salmonella enterica serovar Typhimurium  
Cells were handled as indicated above for 24 mm six-well Costar Transwells.  The LR 
pre-exposure experimental design included treatments of control (no bacterial treatment, but 
appropriate wash steps), ST alone (108 bacteria/well), LR alone (1.5 x 108; about 100 
LR/enterocyte) and three levels of LR pretreated cells: 1.5 x 106 (about one LR/enterocyte; 
designated LR6ST), 1.5 x 107 (about 10 LR/enterocyte; designated LR7ST), and 1.5 x 108 (about 
100 LR/enterocyte; designated LR8ST), followed by ST (108 bacteria/well) challenge.  The BL 
 62
pre-exposure experimental design was similar and included treatments of control (no bacterial 
treatment, but appropriate wash steps), ST alone (108 bacteria/well), BL alone (108; about 66 
BL/enterocyte) and three levels of BL pretreated cells: 106 (< 1 BL/enterocyte; designated 
BL6ST), 107 (about six BL/enterocyte; designated BL7ST), and 108 (about 66 BL/enterocyte; 
designated BL8ST) followed by ST (108 bacteria/well) challenge.  Initially, confluent IPEC-J2 
cells were washed with PBS and 1.0 ml of media alone (control), or diluted LR (or BL) were 
added to the top chamber, while 2.5 ml of media was added to the bottom chamber and plates 
were further incubated at 37°C, 5% CO2 overnight to allow LR or BL pre-exposure before ST 
challenge.  ST was then added directly to the top (apical) wells the following morning and plates 
were further incubated at 37°C, 5% CO2 for 1 h.  Cells from all treatments were then washed and 
both apical and basolateral media were replaced with fresh media containing 50 µg/ml 
gentamicin and incubated at 37°C, 5% CO2 for 4 h for the LR experiment and 5 h for the BL 
experiment.  Then, media were removed from both the apical and basolateral compartments.  
Experiments were replicated four times.   
 
2.6 RNA extraction and reverse transcription (RT) PCR 
Total RNA was extracted at the indicated time points using TRI® Reagent (Sigma-
Aldrich Co., St. Louis, MO) RNA isolation reagent as per the manufacturer’s protocol. 
Following total RNA isolation, the DNA-free™ (Ambion Inc., Austin, TX, USA) kit was used to 
ensure removal of contaminating genomic DNA from all RNA samples.  Samples were frozen in 
50 µl of Nuclease-Free Water (Ambion Inc., Austin, TX, USA).  RNA was quantified by 
spectrophotometry using an optical density of 260 nm.  Reverse transcription was carried out 
using TaqMan® reverse transcription reagents (Applied Biosystems, Foster City, CA, USA). 
Briefly, reverse transcription was carried out in a 50 µl final volume that included 25 mM 
MgCl2, 500 µM dNTP’s, 2.5 µM random hexamers, 0.4 U/µL Rnase inhibitor, 50 U/µL 
MultiScribe reverse transcriptase, and TaqMan RT buffer.  The reverse transcription mixture was 
incubated at 25°C for 10 min, heated to 37°C for 60 min, and inactivated at 95°C for 5 min.  The 
resultant cDNA was stored (-20°C) until used. 
 
2.7 Real time PCR analysis for IL8, CCL20, and TNFα gene expression  
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Real-time quantitative PCR was utilized to quantify the products of interest (IL8, CCL20, 
TNFα) relative to the quantity of 18S rRNA in total RNA isolated from cultured IPEC-J2 cells.  
The PCR reactions were carried out in 96-well plates with the appropriate forward and reverse 
primers (900nM), the appropriate TaqMan TAMRA probe (200 nM), PCR Mastermix (Applied 
Biosystems, Foster City, CA), and 3.5 µL of the cDNA sample.  The sequences for IL8 and 
CCL20 primer-probe sets were as previously published (Skjolaas et al., 2006).  The porcine 
specific TNFα primers and detection probe (forward primer, 5’-3’: TCC AAT GGC AGA GTG 
GGT ATG; reverse primer, 5’-3’: AGC TGG TTG TCT TTC AGC TTC AC; and probe: 5’-3’: 
TGC CCT CCT GGC CAA CGG) were synthesized from a published sequence (GenBank 
Accession: NM_214022) using Primer Express® software (Applied Biosystems, Foster City, 
CA.).  The TNFα probe was synthesized with 6-FAM as the 5’ fluorophore and TAMRA as the 
3’ quencher dye.  Commercially available eukaryotic 18S rRNA (Applied Biosystems, Foster 
City, CA) primers and probe were used as an endogenous control.  Assays using non-template 
controls and samples were performed using the ABI Prism 7000 sequence detection system 
(Applied Biosystems, Foster City, CA).  Thermal cycling parameters were utilized according to 
manufacturer recommendations and included 50 cycles of 15 s at 95°C and 1 min at 60°C.  
Relative expressions of the genes of interest were normalized with the 18S rRNA endogenous 
control. 
 
2.8 ELISA for IL8 
IL8 was quantified in the apical and basolateral supernatants by a porcine specific 
sandwich ELISA (DuoSet® Porcine IL8,  catalog number DY535, R&D systems, Minneapolis, 
MN, USA) as per the manufacturer’s instruction.   
 
2.9 Statistical analysis 
Relative abundance of chemokines and cytokine gene expression were determined from 
real-time PCR data of cultured jejunal enterocytes by the ∆∆CT method using the average ∆CT 
of cells from control wells as the reference expression.  Polarized secretion of IL8 from cultured 
cells were analyzed with effects of treatment, time and location (apical or basolateral) in the 
model for Figure 2, but because Figures 1 and 4 consisted of one time point they were analyzed 
with effects of treatment, location (apical or basolateral) and their interaction in the model.  
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Secretion of IL8 was expressed as pg/well to account for the considerably greater volume of 
media present in the basolateral compartment compared to the apical compartment.  Data bars in 
Figures 1, 3 and 5 represent three observations per treatment obtained from independent in vitro 
experiments.  Data bars in Figure 2 represent six observations per treatment obtained from 
independent in vitro experiments; and Figure 4 represents four observations per treatment 
obtained from independent in vitro experiments.   
3. RESULTS 
3.1 In vitro challenge of swine gut epithelial (IPEC-J2) cells with increasing concentrations of 
Salmonella enterica serovar Typimurium 
This experiment was conducted to evaluate a range of apical ST that would drive strong 
apical and basolateral IL8 secretion (Figure 1).  Cells demonstrated a significant difference in 
IL8 secretion in both the apical and basolateral direction when exposed to 106, 107, and 108 ST 
per well.  At 106 ST per well, IL8 was increased above control wells in the apical (P < 0.01) and 
basolateral (P< 0.0001) directions and demonstrated polarized secretion into the basolateral 
compartment (P < 0.001).  Both the 107 and 108 ST treatments generated maximal IL8 responses 
with highly significant increases in IL8 secretion as compared to controls (P < 0.0001 in both the 
apical and basolateral directions) and both concentrations generated highly significant polarized 
secretion into the basolateral direction (P < 0.0001).  Therefore the use of 108 ST per well for 
proinflammatory stimulation of IPEC-J2 cells was selected for use in future experiments. 
 
3.2 In vitro challenge of IPEC-J2 cells with Salmonella enterica serovars Typhimurium or 
Choleraesuis; or commensal microbes, Lactobacillus reuteri or Bacillus licheniformis 
The aim of this experiment was to individually expose the swine jejunal epithelial cell 
line (IPEC-J2) to two pathogenic bacteria: ST, and SC, as well as two commensal bacterial 
strains LR and BL; and compare the pathogenic and commensal microbe mediated responses.  
To determine whether challenged IPEC-J2 cells demonstrated differential signaling during a 
proinflammatory response, protein secretion of IL8 was evaluated by collection of culture media 
from both the apical and basolateral compartments of Costar Snapwells plates at 1.5, 3.0 and 6.0 
h after bacterial challenge and assayed by ELISA (Figure 2).  The concentration in each 
compartment was adjusted to reflect the greater volume in the basolateral compartment and 
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expressed as pg/well.  Treatment with ST demonstrated an initial trend toward an increase in IL8 
secretion in the basolateral direction (Figure 2B; P =.12) above that of the control basolateral 
compartment at 3 h.  At 6 h post ST (Figure 2C), IL8 secretion was increased in both the apical 
(P < 0.0001) and the basolateral (P < 0.0001) directions relative to controls, and was also 
strongly, though not completely, polarized towards the basolateral compartment (P < 0.0001).  
All other treatments did not affect IL8 secretion at any time point. 
In addition to protein secretion, real time PCR was performed to determine whether the 
above mentioned bacterial strains affected IL8, CCL20, and TNFα, mRNA expression (Figure 
3).  Relative levels of IL8 mRNA were most affected by the ST treatment with increased mRNA 
expression by about ten-fold at 1.5 h and approximately five-fold by both 3 h and 6 h post ST 
relative to control wells (Figure 3A; P < 0.0001 and P < 0.05 respectively). The BL treatment 
also increased IL8 mRNA about seven-fold relative to controls, but only within the first 1.5 h 
post exposure (Figure 3A; P<0.0001).  Neither LR nor SC affected the expression of IL8 mRNA.  
CCL20 mRNA expression exhibited a similar pattern as IL8 demonstrating a strong up-
regulation as a result of ST, BL, and a slight up-regulation by SC.  Treatment with ST increased 
CCL20 by over 150-fold (Figure 3B; P < 0.05), 350-fold (Figure 3B; P < 0.0001), and about 
175-fold (Figure 3B; P < 0.05) at 1.5, 3, and 6 h, respectively.  While treatment with BL 
increased CCL20 by 200-fold at 1.5 h and approximately 125 fold after 3.0 h (Figure 3B; P < 
0.05 for both observations), it did not demonstrated a difference from untreated controls at the 
6.0 h time point.  SC demonstrated a trend toward an increase in CCL20 mRNA by about 75-fold 
at 1.5 and 3 h (Figure 3B; P = 0.166 and P = 0.197 respectively).  Similarly to IL8 mRNA 
expression, CCL20 was unchanged relative to control by the LR treatment.  ST was the only 
bacteria that generated a significant increase in TNFα mRNA relative to control wells, with 
approximately 60, 150, and 80-fold increases at 1.5, 3.0, and 6.0 h respectively (Figure 3C; P = 
.057, P < 0.0001, and P < 0.05, respectively).  The LR, BL, and SC treatments did not affect 
TNFα expression particularly at 3.0 and 6.0 h post treatment.  It may be noteworthy to mention 
that SC and BL demonstrated trends toward an increase in TNFα gene expression at the 1.5 h 
time point with approximately 34 and 45-fold increases respectively (Figure 3C; P = .261 and P 
= .141 respectively).   
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3.3 In vitro challenge of swine gut epithelium with Lactobacillus reuteri or Bacillus licheniformis 
followed by challenge with Salmonella enterica serovar Typhimurium 
Because Lactobacillus and Bacillus spp. are commensal microbes used as a probiotics in 
both domestic animal species and humans, we chose to evaluate whether LR or BL had anti-
inflammatory effects on IPEC-J2 cells challenged with ST.  Cells were initially exposed to 
various amounts of LR or BL overnight followed by ST challenge for 1 h; fresh media were 
collected from both the apical and basolateral compartments at 4 h (LR experiment) or 5 h (BL 
experiment) post ST infection.  As in previous experiments, we evaluated the inflammatory 
response by measuring the IL8 secretion profile (Figures 4 and 5). 
In the experiment involving LR pre-exposure to IPEC-J2 cells, treatment with ST 
increased IL8 in both the apical (Figure 4; P < 0.0001) and the basolateral (Figure 4; P < 0.0001) 
directions relative to controls, and was strongly, though not completely, polarized towards the 
basolateral compartment (P < 0.0001).  Pretreatment with LR (at all concentrations) followed by 
ST challenge failed to change the ST stimulated IL8 secretion profile and all LR+ST co-
treatment wells exhibited the same profile as wells receiving ST alone (Figure 4).  Of particular 
note, the wells that received only LR demonstrated a significantly reduced IL8 secretion profile 
in both the apical and basolateral directions as compared to controls (Figure 4 insert; P < 0.05 for 
both directions).   
Cells pre-exposed to BL and co-cultured with ST demonstrated evaluated IL8 secretion 
(Figures 5). The ST alone treatment stimulated an increase in both the apical and basolateral 
compartments (Figure 5; P<0.0001 for both), with a polarized release in the basolateral direction 
(Figure 5; P<0.05).  Interestingly, and unlike LR, the BL+ST co-treatments (at all levels of BL) 
inhibited ST stimulated basolateral secretion of IL8, and were not different from controls (Figure 
5).  In contrast, the BL alone treatment significantly increased IL8 secretion into the apical 
direction above that of control (Figure 5; P < 0.05). Likewise, the BL+ST co-treatments, BL6ST 
and BL7ST, also stimulated a secretory response into the apical direction with significant 
differences from control (Figure 5; P < 0.001 for BL6ST and BL7ST) and from BL alone (Figure 
5; P<0.05).  Exposure of cells to all BL + ST co-treatments reduced ST induced apical secretion 
of IL8, with the greatest reduction by the BL8ST treatment (Figure 5, P < 0.05).  
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4. DISCUSSION 
As a result of the pursuit to find alternatives to in-feed antibiotics for growth promotion 
in farm animal production a push for a greater understanding of how probiotics may modify the 
gastrointestinal environment and (or) nutritional status has emerged.  Our objective was to 
determine whether two common dietary probiotic microbes (LR and BL) could modulate 
proinflammatory responses in swine jejunal epithelial cells.  We challenged IPEC-J2 cells with 
LR or BL as previously described and included ST and SC as representative pathogenic 
treatments for adequate comparisons of proinflammatory stimulation.  As representative 
proinflammatory mediators, we chose to focus on two chemokines known to regulate the 
chemotaxis of neutrophils (IL8; Eckmann et al., 1993; Fierer et al., 1993; Follin et al., 1991), and 
the trafficking of dendritic cells (CCL20; Dieu-Nosjean et al., 2000; Sierro et al., 2001), along 
with the well known pleiotropic inflammatory cytokine TNFα (Tracey and Cerami, 1994).     
Salmonella was chosen as a prototypic invasive pathogen because of its economic 
importance as a swine enteropathogen that has been extensively characterized in vivo.  Our 
group has shown that single dose oral challenges of young pigs with ST resulted in transient 
enteric disease, fever, inappetence, slowed growth (Balaji et al., 2000; Burkey et al., 2004; 
Turner et al., 2002a; Turner et al., 2002b), activation of the endocrine stress axis (Balaji et al., 
2000) and disruption of the growth axis (Balaji et al., 2000; Jenkins et al., 2004).  In some of our 
experiments we included SC for pathogenic comparison since it is also an important swine 
enteropathogen, but seems to have differing inflammatory properties in vitro (Schierack et al., 
2005; Skjolaas et al., 2006) and in vivo (Reed et al., 1986). 
Lactobacillus and Bacillus species are already in use as probiotics for various domestic 
animal species, and therefore selected as representative commensal bacteria.  Several 
Lactobacillus species isolated from pigs and poultry have been shown to be bile tolerant, able to 
adhere to intestinal cells, inhibit the growth of Salmonella and block Salmonella invasion in 
cultured human cell lines (Casey et al., 2004; Tsai et al., 2005).  Reuterin produced by 
Lactobacillus reuteri spp. also demonstrates antimicrobial activity and has been suggested as 
having a strong probiotic potential in pigs (Rodriguez et al., 2003).  The Bacillus spp. have also 
been evaluated as a probiotic for use in pigs; demonstrating improved health, fertility, and weight 
gain in sows and piglets (Alexopoulos et al., 2004; Zani et al., 1998).   
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We have previously demonstrated that ST is a potent activator of proinflammatory 
signals in IPEC-J2 cells when challenged with 108 CFU/well for 1 h followed by a wash and 
additional incubation in the presence of gentamicin (Skjolaas et al., 2006; Burkey et al., 
submitted).  In the current study, we have further demonstrated that 106 CFU/well is sufficient at 
stimulating a significant IL8 secretory profile with polarized secretion toward the basolateral 
direction; but that maximal secretion occurred with 107 and 108 CFU/well.  Although there was 
no difference in IL8 secretion in either the apical or basolateral compartments between the 107 as 
compared to 108 ST treatments, we chose 108 ST as positive control for all other future 
experiments since this number of bacteria is commonly used for challenge of a variety of 
epithelial cell lines (Eckmann et al., 2000; Gewirtz et al., 2000; Sierro et al., 2001), and the 
activation is designed to stimulate maximal chemokine responses from epithelial cells (Eckmann 
et al., 1997), which seems to be the case for the IPEC-J2 cell line as well.  Schierack et al., 
(2005) challenged IPEC-J2 cells with Salmonella multiplicity of infection of 100:1 (Salmonella: 
enterocyte) for 1 h for evaluation of IL8 secretion. In the current study, our multiplicity of 
infection was approximately 66:1, but IL8 concentrations, both basal and stimulated secretion, 
are comparable to the Schierack study. Therefore, the use of 108 CFU/well for all challenge 
experiments ensured maximal secretion of IL8 for comparison with the commensal microbes. 
In evaluating whether the commensal strains could affect inflammatory signals when 
cultured with IPEC-J2 cells, we found that neither the LR nor the BL strain elicited a secretory 
IL8 response at any time point evaluated.  However, BL was able to induce upregulation of IL8, 
CCL20, and TNFα mRNA expression, albeit an early response that was extinguished by 3 and 6 
h.  Previously, ST was found to be more potent than SC in stimulating both IL8 and CCL20 
mRNA, and in stimulating IL8 secretion in swine epithelial cells (Skjolaas et al., 2006).  The 
data presented here support our previous finding.  Consistent with this observation, Schierack et 
al., (2005) observed reduced invasion efficiency by SC as compared to ST into the IPEC-J2 cell 
line.  The lack of an inflammatory response by LR or BL suggests that these microbes co-exist 
with the gastrointestinal epithelium without triggering proinflammatory alarm responses.   
Since BL and LR did not stimulate an inflammatory response, we next evaluated whether 
they could affect the inflammatory response to ST.  Numerous studies have provided evidence 
for the beneficial protective effects of Lactobacillus species against pathogenic bacteria, which 
include blocking entry and inhibiting growth (Tsai et al., 2005).  Our data suggest that LR 
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offered no protection against ST induced IL8 secretion in IPEC-J2 cells since all wells co-treated 
with LR and ST exhibited significant increases in IL8 secretion, similar to wells treated with ST 
alone.  The co-treatment of LR with ST contrasts results obtained where LR (at 10 bacteria/cell) 
reduced 107 ST stimulated IL8 response from T84 human enterocytes (Ma et al., 2004).  The 
contrast of their results to ours may be related to the particular Lactobacillus reuteri strain, since 
not all strains have demonstrated equal adhesion ability to Caco-2 cells (Todoriki et al., 2001).  
The inability of LR in the current study to affect ST mediated IL8 secretion may also be due to 
culture conditions required by IPEC-J2 cells, as DMEM has been shown to delay the killing 
activity of lactic acid. Since inhibition of ST growth depends on the pH lowering effect of 
Lactobacillus spp. (Fayol-Messaoudi et al., 2005), our pH conditions may not have been optimal 
for LR.  However, in our experiment, LR may have promoted an enhanced anti-inflammatory 
condition in our model epithelium as LR exposure of IPEC-J2 cells resulted in IL8 accumulation 
in the media that was significantly lower than control wells not exposed to any bacteria.   
When we evaluated whether BL offered any protection against ST mediated IL8 secretion 
by IPEC-J2 cells, we found that BL pre-treatment followed by BL and ST co-culture resulted in 
a diminished IL8 secretion in the basolateral direction.  Therefore, BL may inhibit ST mediated 
stimulation of inflammatory signals, but further investigation is warranted to determine if this 
was due to BL blocking ST adhesion and entry, or by an antibiotic mediated inhibition of ST. 
The latter seems plausible since ATCC 10716 BL, employed in our experiment, is known to 
produce bacitracin (Konz et al., 1997), and overnight cultures in LB media have produced as 
much as 30.0 ± 3.9 units/ml of antibiotics (Ishihara et al., 2002). 
The contrasting effects of BL treatment on IL8 secretion comparing those in Figure 2 (at 
6 h) and Figure 5 is almost certainly attributable to the more prolonged incubation of the cells 
with BL (in Figure 5). In that regard, treatment of IPEC-J2 cells with BL alone increased IL8 
secretion, but only in the apical direction. This raises the intriguing question of whether BL 
within the gut luminal contents could impose a persistent stimulation of IL8 towards the gut 
lumen. Such an effect would be presumed to generally not be inflammatory, and likely 
ineffective in stimulating neutrophil invasion. 
In conclusion, in a model swine gut epithelium, ST stimulated increased IL8 secretion, as 
well as IL8, CCL20, and TNFα mRNA, with levels varying according to time.  In contrast, IL8 
secretion and IL8, CCL20, and TNFα gene expression were unaffected by LR or BL.  
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Enterocytes pre-treated with either BL or LR and co-cultured with ST demonstrated that BL, but 
not LR, inhibited ST stimulated IL8 secretion in the basolateral direction.  These observations 
shed new light on the potential interaction of probiotic bacteria with intestinal epithelium and 
their potential to modulate inflammatory responses of enterocytes to invasive enteropathogens. 
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 Figure 3.1 Polarized interleukin 8 (IL8) secretion by confluent porcine jejunal epithelial cell 
(IPEC-J2) monolayers treated with media alone (control; CTL),  104, 105, 106, 107, or 108 
CFU/well Salmonella enterica serovar Typhimurium (ST4, ST5, ST6, ST7, or ST8, respectively) 
in the apical compartment for 1 h. Treatment media were removed and replaced with media 
containing gentamicin. Media from the apical and basolateral compartments were collected and 
assayed for cytokines at 5.0 h after the onset of bacterial treatment.  Each bar represents the least 
square mean (± SEM) of four observations.  Within each secretory direction, bars without 
common superscripts differ (P < 0.05).  Significant accumulation of IL8 was observed in wells 
treated with ST at 106, 107, or 108 CFU/well, with greater secretion in the basolateral direction.  
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Figure 3.2 Polarized interleukin 8 (IL8) secretion by confluent porcine jejunal epithelial cell 
(IPEC-J2) monolayers treated with media alone (control; CTL), 108 CFU/well Salmonella 
enterica serovar Typhimurium (ST), 108 CFU/well Choleraesius (SC), 108 CFU/well 
Lactobacillus reuteri (LR), or 108 CFU/well Bacillus licheniformis (BL) in the apical 
compartment for 1 h. Treatment media were removed and replaced with media containing 
gentamicin. Media from the apical and basolateral compartments were collected and assayed for 
cytokines at 1.5, 3.0, and 6.0 h after the onset of bacterial treatment. Each bar represents the least 
square mean (± SEM) of six observations.  Significant accumulation of IL8 was observed at 6 h 
in wells treated with ST, with greater secretion in the basolateral direction. 
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Figure 3.3 Relative abundance of interleukin 8 (IL8; panel A), macrophage inflammatory protein 
(MIP)3α/CC chemokine ligand-20 (CCL20; panel B) and Tumor necrosis factor-alpha (TNFα; 
panel C) mRNA from cultured porcine jejunal epithelial cells (IPEC-J2) treated with media alone 
(control; CTL),  108 CFU/well Salmonella enterica serovar Typhimurium (ST), 108 CFU/well 
Choleraesius (SC), 108 CFU/well Lactobacillus reuteri (LR), or 108 CFU/well Bacillus 
licheniformis (BL) in the apical compartment for 1 h.   Total RNA extracted at 1.5, 3.0 and 6.0 h 
post treatment. Each bar represents the least square mean (± SEM) of three observations. Within 
time periods, bars without common superscripts differ (P < 0.05). 
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 Figure 3.4 Polarized interleukin 8 (IL8) secretion by confluent porcine jejunal epithelial cell 
(IPEC-J2) monolayers treated with media alone (control; CTL), or apical overnight exposure to 
1.5 x 106, 1.5 x 107, or 1.5 x 108 CFU/well Lactobacillus reuteri followed by apical challenge 
with 108 CFU/well Salmonella enterica serovar Typhimurium (ST) for 1 h (LR6ST, LR7ST, 
LR8ST).  Treatment with 108 LR alone or ST alone served as positive controls (LR and ST, 
respectively). Treatment media were removed and replaced with media containing gentamicin. 
Media from the apical and basolateral compartments were collected and assayed for cytokines at 
4.0 h after the onset of ST treatment. Each bar represents the least square mean (± SEM) of four 
observations. Within each secretory direction, bars without common superscripts differ (P < 
0.05).  Significant accumulation of IL8 was observed in wells treated with ST regardless of the 
presence of LR, with greater secretion in the basolateral direction.  Treatment with LR stimulated 
less IL8 in both the apical and basolateral compartments relative to control (insert). 
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 Figure 3.5 Polarized interleukin 8 (IL8) secretion by confluent porcine jejunal epithelial cell 
(IPEC-J2) monolayers treated with media alone (control; CTL), or apical overnight exposure to 
106, 107, or 108 CFU/well Bacillus licheniformis followed by apical challenge with 108 CFU/well 
Salmonella enterica serovar Typhimurium (ST) for 1 h (BL6ST, BL7ST, BL8ST). Treatment 
with 108 BL alone or ST alone served as positive controls (BL and ST, respectively). Treatment 
media were removed and replaced with media containing gentamicin. Media from the apical and 
basolateral compartments were collected and assayed for cytokines at 5.0 h after the onset of ST 
treatment. Each bar represents the least square mean (± SEM) of three observations. Within each 
secretory direction, bars without common superscripts differ (P < 0.05). Significant accumulation 
of IL8 was observed in wells treated with ST alone with greater secretion in the basolateral 
direction, whereas BL treatments significantly increased accumulation only in the apical 
direction and inhibited ST stimulated secretion in the basolateral direction. 
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 CHAPTER 4 - Characterization of the swine CC chemokine ligand 
20 mRNA sequence and evaluation of gene expression in tissues 
from healthy pigs and pigs exposed to Salmonella enterica serovar 
Typhimurium or serovar Choleraesuis 
ABSTRACT 
The gastrointestinal epithelium represents a barrier to potentially invasive enteric 
pathogens, maintains a role in innate immune surveillance, and is a source of chemokine and 
cytokine mediators. CC chemokine ligand 20 (CCL20) is responsible for the recruitment of 
dendritic cells and T cells to assist in gastrointestinal immune defense.  In the current study, we 
characterized the swine CCL20 mRNA sequence and evaluated its expression in various 
gastrointestinal and immune associated tissues.  Cloning of CCL20 from the porcine jejunum 
predicted a 97 amino acid peptide.  An in vivo experiment was conducted to determine tissue 
CCL20 gene expression comparisons among tissues from healthy pigs, and in tissues from pigs 
responding to the invasive swine enteropathogens Salmonella enterica serovar Typhimurium 
transformed with green fluorescent protein (STG) or serovar Choleraesuis transformed with red 
fluorescent protein (SCR). For this study, 24 weaned pigs were fed 108 CFU of STG or SCR in 
cookie dough, or dough without bacteria (control) on days 0, 3, 7 and 10 of the study. Pigs were 
sacrificed 14 d after the initial challenge and total RNA was extracted from the tonsil, jejunum, 
ileum, colon, mesenteric lymph node (MLN), spleen, and liver.  In uninfected control pigs, 
substantial variation in CCL20 mRNA was observed (P < 0.0001), with greatest abundance in 
tonsil and colon (3500-fold and 5000-fold relative to spleen, respectively), about 1500-fold in 
jejunum, ileum, and MLN, and lowest in liver (not different from spleen). Feeding pigs STG for 
14 d did not affect CCL20 mRNA abundance in tissues compared to control pigs. Feeding SCR 
stimulated a modest increase in CCL20 in spleen (approximately threefold increase), and about a 
26-fold increase in liver (P < 0.05 for both, compared to control pigs), but did not affect CCL20 
mRNA in other tissues.  These data suggest that tissues of the porcine gastrointestinal tract and 
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MLN are prominent sources CCL20 in pigs, and that repeated oral exposure of pigs to host-
adapted Salmonella serovar Choleraesuis, but not serovar Typhimurium, increased CCL20 in 
liver and spleen, tissues that otherwise have relatively low CCL20 expression. 
 
1. INTRODUCTION 
Healthy pigs in production settings maintain a dynamic population of immune cells in the 
lamina propria with close association to the gastrointestinal epithelium. This population of cells 
is thought to be influenced by both commensal and pathogenic microbiota resulting in 
chemotactic signals that recruit and maintain the appropriate immune cell types.  The presence of 
invasive enteric pathogens can provoke increased migration of cells into the lamina propria and 
subepithelium, and salmonellae organisms are known swine enteric pathogens that have long 
been associated with neutrophil infiltration into affected mucosal sites (Rothkotter et al., 1999). 
Two serovars of Salmonella enterica, serovar Typhimurium (ST) and serovar 
Choleraesuis (SC) account for the vast majority of salmonellosis in pigs (Schwartz, 1999; 
Taylor, 1999). The serovars differ in their pathogenicity to pigs with ST producing self-limiting 
enteritis, and SC, the so-called host adapted serovar, potentially producing systemic disease 
(Schwartz, 1999; Meyerholz and Stabel, 2003). There is compelling evidence that enterocytes 
are instrumental in generating chemotactic signals in response to enteric pathogens, including ST 
(Eckmann et al., 1997). Gastrointestinal enterocytes substantially outnumber microfold cells in 
the gut epithelium (Eckmann and Kagnoff, 2001), even in Peyer’s patches (Gebert et al., 1996), 
which suggests that enterocytes also serve important roles in immune cell recruitment in 
response to salmonellae organisms.  CC chemokine ligand 20 (CCL20) is one such chemokine 
that functions as a chemoattractant for CD34+ immature dendritic cells and CD45RO+ memory 
T cells, expresses major expression in the gastrointestinal tract including the colon, small 
intestine, and appendix (Kunkel et al., 2003; Kwon et al., 2002; Tanaka et al., 1999)  and is 
increased after stimulation with either TNFα, IL1α, or exposure to Salmonella (Izadpanah et al., 
2001). 
Here we report on the characterization of the mRNA sequence for the putative swine 
CCL20 gene, also termed macrophage inflammatory protein 3α (MIP3α) (Hieshima et al., 1997).  
We also evaluated the constitutive distribution of CCL20 in tissues from healthy (control) pigs 
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obtained from an in vivo experiment designed to determine changes in expression of CCL20 
mRNA in tissues of the gastrointestinal tract, mesenteric lymph node (MLN), spleen and liver 
following a repeated exposure to salmonellae serovars transformed with green (STG) and red 
(SCR) fluorescent proteins.  Our working hypothesis was that the repeated low dose exposure of 
pigs to invasive bacterial pathogens (designed to model fecal to oral transmission of Salmonella 
in swine production settings) would trigger the upregulation of CCL20, particularly in 
gastrointestinal tissues.   
 
2. METHODS AND MATERIALS 
2.1 Cloning CCL20 
Using human CCL20 sequences (GenBank™ accession number: BC020698) a tBlastx 
algorithm-based search was conducted using the sequence tag (EST) databases for the pig (TIGR 
Pig Gene Index, The institute for Genomic Research, http://www.tigr.org/tigr-
scripts/tgi/T_index.cgi? species=pig).  The EST clones (CF179066.1, CB287066.1 and 
CB287401.1) which contained CCL20 homologous sequences in its translated region were 
therefore selected for use.  To identify porcine CCL20, 5’ and 3’ rapid amplification of cDNA 
ends (FirstChoice® RLM-RACE kit, Ambion® Inc., Austin, TX) in conjunction with high 
throughput clone selection techniques were utilized.  Nested gene specific 5’ and 3’ RACE 
primers based on the EST clones were as follows: outer sense 5’-AAA ATG ATG TGC AGT 
AGC AAG AGT T-3’, outer antisense 5’-GTC CAT ATA ATC TCA TTC CTC CAA AC-3’; 
inner sense 5’-CTC CGA TAT ACA GAC CAT ATT CTT CA-3’, inner antisense 5’-ATC AGA 
TGA GCT CAG AAG TCT CAG TA-3’.  Total RNA from porcine jejunal samples collected 
from ST challenged pigs was extracted with TRI® Reagent (Sigma-Aldrich Co., St. Louis, MO) 
using the manufacturer’s protocol. Following total RNA isolation, the DNA-free™ (Ambion 
Inc., Austin, TX) kit was used to ensure removal of contaminating genomic DNA from all RNA 
samples.  Samples were frozen in 50 µl of Nuclease-Free Water (Ambion Inc., Austin, TX).  The 
5’ and 3’ RACE products were obtained by PCR amplification using adapter primers provided 
by the kit along with the CCL20 specific primers described above.  The PCR products were then 
ligated into pCR®4-TOPO®  and transformed into One Shot® Mach1™-T1r competent E. coli 
cells (TOPO TA Cloning® Kit for Sequencing, Invitrogen™, Carlsbad, CA).  Plasmids were 
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isolated from the positive clones (QIAprep® Spin Miniprep, Valencia, CA), screened by PCR 
and sequenced (DNA Sequencing and Genotyping Facility, Dept. of Plant Pathology, Kansas 
State University, and DNA Sequencing Laboratory, Department of Microbiology and 
Immunology, University of Arkansas for Medical Sciences) to characterize the cDNA of porcine 
CCL20.  
 
2.2 Bacterial strains and culture conditions.  
ST and SC isolates from swine origin were obtained from Dr. Jerome Nietfeld,  
Diagnostic Medicine Pathobiology, Kansas State University, and identification of Salmonella 
serotypes was further verified by National Veterinary Services Laboratory, Ames Iowa, USA.  
SC was transformed with red fluorescent protein (SCR) utilizing the kanamycin resistant 
pDsRed-Express-1 vector (catalog no. 6994-1, BD Biosciences Clontech, Palo Alto, CA; a lac Z 
promoter was cloned into this vector upstream of DsRed-Expression coding sequence).  ST was 
transformed with green fluorescent protein (STG) by first modifying the pDsRed-Express-1 
vector (BD Biosciences).  To modify the pDsRed-Express-1 vector, the DsRed-Express coding 
sequence was excised and the GFPuv coding sequence from the pGFPuv vector (BD Biosciences 
Clontech) was inserted into the modified pDsRed-Express-1 vector.  Bacteria were transformed 
as described previously (Sanderson et al., 1995).  Both STG and SCR were grown in Luria 
Bertani medium at 37°C for 24 hr, at which point bacterial populations were estimated by 
spectrophotometry at 600 nm optical density.  Bacteria were then pelleted and resuspended in 
PBS at a concentration of 1010 CFU/ml, 10 µL of the appropriate treatment (STG, SCR, or 
control) was added to cookie dough balls and fed to each pig (providing 108 CFU/pig). This oral 
dosage of bacteria was derived empirically based on the lowest range of Salmonella resulting in 
disease in pigs and the number of Salmonella potentially shed from pig feces (Fedorka-Cray et 
al., 2000). 
 
2.3 Animal challenge protocol and tissue collection 
This experimental protocol was approved by the Kansas State University Institutional 
Animal Care and Use Committee before initiation of the study. Twenty four crossbred pigs, 
typical of commercial pigs and approximately 5 wk of age, were used and showed no clinical 
signs or laboratory evidence of salmonellosis or any other enteric diseases.  Pigs were penned as 
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groups of two in an environmentally controlled isolation facility at 25°C and under constant light 
with ad libitum access to feed and water. The diet was typical of commercial nursery diets, but 
was free of added antibiotics and growth promoting levels of copper and zinc. After an 
acclimation period of 7 d, pigs were fed 108 CFU STG (n=8) or STR (n=8) on days 0, 3, 7, and 
10, while the control group (n = 8) received dough without added bacteria.  The use of 
transformed bacteria was chosen to assist in the isolation of the respective pathogens after animal 
passage, which was utilized for the repeated challenges at d 3, 7, and 10.  Samples of tonsil, 
jejunum, ileum, colon, MLN, spleen, and liver, were removed aseptically from weaned pigs at 
sacrifice 14 d after initial salmonella challenge, rapidly frozen in liquid nitrogen and stored at -
80°C for subsequent RNA isolation.  In addition to the evaluation of CCL20 as reported here, we 
also evaluated selected TLRs and proinflammatory cytokines and (or) chemokines gene 
expression profiles (Burkey et. al., 2006; submitted), as well as growth performance and selected 
immune responses in vivo (Fraser et al., 2006; submitted) from pigs in this study. 
 
2.4 RNA extraction and reverse transcription (RT) PCR 
Total RNA was extracted using TRI® Reagent (Sigma-Aldrich Co., St. Louis, MO) RNA 
isolation reagent as per the manufacturer’s protocol. Following total RNA isolation, the DNA-
free™ (Ambion Inc., Austin, TX) kit was used to ensure removal of contaminating genomic 
DNA from all RNA samples.  Samples were frozen in 50 µl of nuclease-free water (Ambion Inc., 
Austin, TX).  RNA was quantified by spectrophotometry using an optical density of 260 nm. 
RNA quality was verified by agarose gel electrophoresis and visualization of the 28S and 18S 
ribosomal RNA.  Reverse transcription was carried out using TaqMan® reverse transcription 
reagents (Applied Biosystems, Foster City, CA).  Briefly, reverse transcription was carried out in 
a 50 µl final volume that included 25 mM MgCl2, 500 µM dNTP’s, 2.5 µM random hexamers, 
0.4 U/µl RNase inhibitor, 50 U/µL MultiScribe reverse transcriptase, and TaqMan RT buffer.  
The reverse transcription mixture was incubated at 25°C for 10 min, heated to 37°C for 60 min, 
and inactivated at 95°C for 5 min.  The resultant cDNA was stored (-20°C) until used. 
 
2.5 Real time PCR analysis for gene expression  
Real-time quantitative PCR was utilized to quantify CCL20 relative to the quantity of 
18S rRNA in total RNA isolated from porcine tissue samples.  The PCR reactions were carried 
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out in 96-well plates with the appropriate forward and reverse primers (900nM), the appropriate 
TaqMan TAMRA probe (200 nM), PCR Mastermix (Applied Biosystems, Foster City, CA), and 
3.5 µL of the cDNA sample.  The porcine specific CCL20 primers and detection probes were 
synthesized from published GenBank sequences using Primer Express® software (Applied 
Biosystems, FosterCity, CA); forward primer, 5’-3’: GCTCCTGGCTGCTTTGATG, reverse 
primer 5’-3’: CAGTCAAAG TTGCTTGCTTCTGA, and probe 5’-3’: 
CGGTGCTGCTCTACCTCTGCA.  The CCL20 probe was synthesized with 6-FAM as the 5’ 
fluorophore and TAMRA as the 3’ quencher dye.  Commercially available eukaryotic 18S rRNA 
(Applied Biosystems, Foster City, CA) primers and probe were used as an endogenous control.  
Assays using non-template controls and samples were performed using the ABI Prism 7000 
sequence detection system (Applied Biosystems, Foster City, CA).  Thermal cycling parameters 
were utilized according to manufacturer recommendations and included 50 cycles of 15 s at 95°C 
and 1 min at 60°C.  Relative expression of mRNA was normalized with the 18S rRNA 
endogenous control. 
 
2.6 Statistical analyses 
To determine basal levels of expression as well as differences in the relative abundance 
of CCL20 mRNA among the tissues collected from control animals, the ∆∆CT method was used 
with the average spleen ∆CT for CCL20 set as the reference expression (n = tissue from eight 
pigs).  The ∆∆CT values were expressed as 2-∆∆CT to obtain relative abundance.  The relative 
abundance values were then square root transformed to ensure homogeneity of variance and 
analyzed by the PROC MIXED procedure of SAS (SAS Inst. Inc., Cary, NC), with tissue in the 
model.  To facilitate depiction of the data, relative abundance values were back transformed and 
illustrated in Figure 3.    
Differences in relative abundance of CCL20 mRNA in each of the individual tissue types 
as a result of STG and SCR feeding were also determined using the ∆∆CT method with the 
average control ∆CT as the reference expression (n = tissue from eight control pigs per 
treatment).  The ∆∆CT values were expressed as 2-∆∆CT to obtain relative abundance values, 
which were then square root transformed to ensure homogeneity of variance, and analyzed using 
the PROC MIXED procedure of SAS with treatment in the model.  To facilitate depiction of the 
data, relative abundance values were back transformed and illustrated in Figure 4.    
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3. RESULTS 
3.1 Characterization of cDNA encoding CCL20 
The cDNA sequence obtained from RLM RACE generated a 564 nucleotide sequence 
(Figure 1), which translated into a 97 amino acid protein (The Sequence Manipulation Suite; 
http://www.ualberta.ca/~stothard/javascript/reference.html (Stothard, 2000)) confirmed to be 
porcine CCL20 (NCBI Blastx 2.2.12; http://www.ncbi.nlm.nih.gov/BLAST/).  Results of 
multiple protein sequence alignment as determined by CLUSTAL W (ClustalW WWW Service 
at the European Bioinformatics Institute, http://www.ebi.ac.uk/clustalw, Rodrigo Lopez, Services 
Program; Figure 2A) with PubMed porcine (CAE11786), bovine (NP_776688), canine 
(BAD42361), and human (NP_004582) sequences indicating that our CCL20 had the highest 
sequence score (98) with the already published pig sequence (Figure 2B), followed by the bovine 
(82) and canine (82) sequences, and was least similar to the human sequence (76).   
 
3.2 CCL20 mRNA distribution in healthy porcine tissues 
Tissue samples, including the tonsil, jejunum, ileum, colon, MLN, spleen, and liver were 
collected from control animals (from the STG and SCR feeding experiment) to evaluate the 
relative expression of CCL20 mRNA in apparently healthy pigs (Figure 3). The lowest CCL20 
expression was in the spleen and liver, and spleen was chosen as the reference tissue for 
computation of ∆∆CT.  Relative abundance of CCL20 mRNA was greatest in colon and tonsil 
(approximately 3500-fold and 5000-fold greater respectively; P < 0.0001 for both, relative to 
spleen), followed by an approximately 1500-fold greater abundance in the jejunum, ileum, and 
MLN (P < 0.0001 for all, relative to the spleen).   
 
3.3 CCL20 mRNA distribution in tissues from pigs STG or SCR 
This experiment was designed to evaluate the effect of repeated low dose oral STG or 
SCR challenge on CCL20 mRNA expression in the above mentioned tissues (Figure 4).  The 
expression of CCL20 was unaffected by either STG or SCR in the tonsil, jejunum, ileum, colon, 
and MLN (Figure 4: A, B, C, D, and E).  However, pigs fed SCR had increased abundance of 
CCL20 in the spleen (approximately three-fold increase above controls; Figure 4F, P = 0.059) 
and the liver (approximately 26 fold increase above controls; Figure 4G, P = 0.087).   
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4. DISCUSSION 
The chemokine CCL20, is also known as macrophage inflammatory protein 3α (MIP3α) 
(Hieshima et al., 1997), liver and activation regulated chemokine (LARC) (Hieshima et al., 
1997), and Exudos-1 (Hromas et al., 1997), and is expressed abundantly in the gastrointestinal 
tract, including the colon, small intestine, and appendix. The expression of CCL20 in 
gastrointestinal cell lines seems to vary with the cell type and the type of stimuli.  Several human 
intestinal cell lines express CCL20 mRNA and produce the secreted CCL20 protein; both of 
which are increased after TNFα, IL1α, or exposure to Salmonella or Escherichia coli (Izadpanah 
et al., 2001).  However, differences between cell lines has also been noted, in that several have 
constitutive expression (e.g. HT-29, Caco-2, LS174T, and I-407), while others demonstrate 
regulated (HT29 and Caco-2) expression of CCL20 mRNA (Izadpanah et al., 2001).  The swine 
intestinal epithelial line IPEC-J2 constitutively expresses CCL20 mRNA which is upregulated 
substantially upon exposure to both SC and ST (Skjolaas et al., 2006).  In addition, IPEC-J2 cells 
demonstrated an upregulation of CCL20 mRNA upon exposure to the transformed bacteria 
utilized in this study, confirming pathogenicity of these enteropathogens after transformation 
(Burkey et al., 2006).   
The 397 bp Sus scrofa putative CCL20 chemokine mRNA sequence as determined from 
the lymph node has been reported in PUBMED (http://www.ncbi.nlm.nih.gov/entrez 
/query.fcgi?CMD=search&DB=pubmed; accession: AJ577084, author: Ezquerra,A.). The 
mRNA sequence for CCL20 has also been sequenced for Homo sapiens NM_004591, Bos taurus 
NM_174263,  Canis familiaris NM_001005254, Rattus norvegicus NM_019233, and Mus 
musculus NM_016960.  We characterized and further evaluated the porcine CCL20 mRNA 
sequence and gene distribution in swine gastrointestinal and lymphoid tissues to confirm its 
sequence and to further describe its distribution and associated function in healthy young pigs as 
well as in pigs challenged with two common and economically important swine enteropathogens.  
The sequence we obtained from cloning via RLM RACE complement those from the pig 
reported previously (PUBMED accession AJ577084). 
The in vivo expression of CCL20 expression has been described for other species, but 
limited information is available in the domestic pig. The normal human colon demonstrates 
minimal constitutive CCL20 mRNA expression, whereas inflammation induced major 
upregulation of its expression (Izadpanah et al., 2001).  The ileum from healthy pigs also 
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constitutively expressed CCL20 mRNA and was increased by approximately 24 h post oral ST 
challenge (Skjolaas et al., 2006).  In the mouse model, variable expression has been observed in 
the gastrointestinal tract, depending mainly on the mouse strain, tissue type, and (or) the 
inflammatory stimulus used. For example, BALB/c mice have constitutive CCL20 expression in 
the colon and appendix (Tanaka et al., 1999).  Yet, the small intestine of BALB/c mice failed to 
demonstrate a strong constitutive expression which is in contrast to the C57BL/6 mice strain 
(Tanaka et al., 1999) .  The expression of CCL20 is also altered upon stimulation with LPS, 
whereby BALB/c mice exhibited a reduced expression of CCL20 in the colon and appendix, and 
a strong increase in mRNA expression in the small intestine (Tanaka et al., 1999).   
Swine gastrointestinal tissues and MLN collected in this study (including the jejunum, 
ileum, and colon) had constitutive expression of CCL20 mRNA, but we did not see an increase 
or decrease in CCL20 mRNA expression as a result of STG or SCR exposure in any of the 
gastrointestinal tissues evaluated. As noted above, pigs exposed to a single oral gavage of 1010 
ST experienced rapid upregulation of CCL20 which occurred 24 h after challenge, with a return 
to basal mRNA expression by 48 h after exposure (Skjolaas et al., 2006). It is possible; therefore, 
that CCL20 may have been increased acutely by STG, and perhaps SCR, in gastrointestinal 
tissue, but waned with repeated exposure to bacteria over 14 d. 
Aside from the gastrointestinal tract, the expression of CCL20 has been documented in 
normal human liver, lung, appendix, tonsil, lymph nodes, peripheral blood leukocytes, thymus, 
fetal liver, fetal lung, small intestine, colon epithelial cells, stomach, bladder, pancreas, testis, 
cervix epithelial cells, placenta, and skin (Schutyser et al., 2003).  Our results demonstrate that 
aside from the aforementioned swine jejunum, ileum, colon, and MLN, the tonsil, spleen, and 
liver also constitutively express CCL20 mRNA, although the pig liver and spleen express the 
chemokine at relatively low levels. 
In the current study, only SCR altered CCL20 gene expression where an increase was 
observed in liver and spleen. That STG failed to similarly affect CCL20 in liver and spleen may 
be explained by reported differences in patterns of mucosal invasion between the serovars. The 
so-called host adapted serovar SC is more likely to aggressively invade disparate mucosal sites 
and establish systemic disease than ST (Meyerholz and Stabel, 2003; Schierack et al., 2005). 
Moreover, of particular interest is the observation that SCR induced upregulation in tissues that 
otherwise demonstrated the lowest expression in healthy animals. In a separate report evaluating 
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growth performance of these same animals, pigs fed SCR had substantially reduced growth rate 
compared to pigs fed STG (Fraser et al., 2005). It is tempting to speculate that the invasive 
nature of SC may upregulate CCL20 and other immune mediators as activated immune cells 
traffic to affected tissues. Such activation may represent a substantial nutrient drain that 
contributes to slowed growth. 
In conclusion, we have characterized the constitutive expression of swine CCL20 in 
various gastrointestinal and lymphoid tissues of healthy young pigs.  We have also shown that 
repeated exposure of two Salmonella serovars in the pig gastrointestinal tract triggered 
alterations in CCL20 expression levels varying with serovar and (or) tissue type.  Relative to the 
Salmonella spp. challenge, STG exposure triggered a lesser response among the tissues 
evaluated.  These differences may partially underlie the differences between the two Salmonella 
serovars in eliciting distinct disease pathogenesis in swine.  
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Figure 4.1 Putative porcine CCL20 mRNA sequence, translated by The Sequence Manipulation 
Suite, red indicates amino acid sequence.   
 
                M  M  C  S  S  K  S  L  L  L  A  A  L  M  S  V  L  
L  L  Y  L  C  S  K  S  E  A  A  S  N  F  D  C  C  L  R  Y  
T  D  H  I  L  H  P  R  F  I  M  G  F  T  Q  Q  L  A  N  E  
    A  C  D  I  N  A  I  I  F  Y  T  K  K  K  L  A  V  C  A  D  
P  K  K  I  W  V  K  Q  A  V  N  I  L  S  Q  R  V  K  K  M  
*                     
         CGCCCTTAAAATGATGTGCAGTAGCAAGAGTTTGCTCCTGGCTGCTTTGATGTCGGTGCT 
          
    
         GCTGCTCTACCTCTGCAGCAAGTCAGAAGCAGCAAGCAACTTTGACTGCTGCCTCCGATA 
          
          
         TACAGACCATATTCTTCACCCCAGATTTATCATGGGCTTCACACAGCAGCTCGCCAATGA 
   
   
         AGCTTGTGACATCAATGCAATCATCTTTTACACAAAGAAAAAGTTAGCCGTGTGTGCAGA 
 
          
         TCCAAAGAAGATCTGGGTGAAACAAGCCGTGAATATCCTCAGTCAAAGAGTCAAGAAGAT 
   
         GTAAAAACAGATGCTCCCTGCTATGGAATTGGACACAGCCCAAGAACAAAAAGAACCTCG 
                    
         CTGTGCTGGTGGTTTCACTTACACATTACTGAGACTTCTGAGCTCATCTGATCTGTGCCT 
          
         CTTTGGACTTGTCCAATTAATGAAGTTGATTCATATTGCATCATAGTTCGCTTTGTTAAG 
                     
         CATCATGTTATACTCTATTTTATGTTATGTTATTTATATGTGTAGTTTTCTTGTGTGCCT 
          
         TGCTATTTAATACTAGTTTTCTACAAGGCCATT 
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Figure 4.2 Putative porcine CCL20 protein sequence alignments (A)  and comparisons (B) of 
CCL20 protein sequences for KSU_pig, to pig (pubmed: CAE11786), human (Pubmed: 
NP_004582), Bovine (Pubmed: NP_776688), and canine (Pubmed: BAD42361).  According to 
ClustalW, "*" means the residues or nucleotides in that column are identical in all sequences in 
the alignment, ":" means that conserved substitutions have been observed, and "." means that 
semi-conserved substitutions are observed. 
A)  
 
KSU_PIG         MMCSSKSLLLAALMS-VLLLYLCSKSEAASNFDCCLRYTDHILHPRFIMGFTQQLANEAC 59
pig             -MCSSKSLLLAALMS-VLLLYLCSKSEAASNFDCCLRYTDHILHPRFIMGFTQQLANEAC 58
bovine          MMCSSKNLLLAALMS-VLLLHFCSKSE-ASNFDCCLRYTERILHPSILVGFTQQLANEAC 58
canine          -MCSSKNLLLAALMMSVLLLHLCSKSEAASNFDCCLRYTEHMVPPGSIMGFTQQLANEAC 59
human           -MCCTKSLLLAALMS-VLLLHLCGESEAASNFDCCLGYTDRILHPKFIVGFTRQLANEGC 58
                 **.:*.*******  ****::*.:**:******** **:::: *  ::***:*****.* 
 
KSU_PIG         DINAIIFYTKKKLAVCADPKKIWVKQAVNILSQRVKKM 97 
pig             DINAIIFYTKKKLAVCADPQKIWVKQAVNILSQRVKKM 96 
bovine          DINAVVFYTRKKLAVCADPKKKWVKQVVHMLSQRVKRM 96 
canine          DINAVIFYTKKKKAVCADPKKKWVKRTVRLLSHRVKKM 97 
human           DINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM 96 
                ****::*:*:** :***:*:: ***  *.:**::**.* 
 
(B) 
 
SeqA Name      Len(aa)  SeqB Name      Len(aa)  Score 
===================================================== 
1    KSU_PIG   97       2    pig       96       98    
1    KSU_PIG   97       3    human     96       76    
1    KSU_PIG   97       4    bovine    96       82    
1    KSU_PIG   97       5    canine    97       82     
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Figure 4.3 Relative abundance of macrophage inflammatory protein (MIP) 3α/CC chemokine 
ligand-20 mRNA from healthy porcine tonsil, jejunum, ileum, colon, MLN, spleen, and liver.  
Each bar represents the least square mean (± SEM) of eight observations, and bars without 
common superscripts denote significant differences (P < 0.05). 
Tissue P < 0.0001
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Figure 4.4 Relative abundance of macrophage inflammatory protein (MIP)3α/CC chemokine 
ligand-20 (CCL20) mRNA from porcine tonsil, jejunum, ileum, colon, MLN, spleen, and liver 
after repeated oral challenge (days 0, 3, 7, 10) with 108 CFU of Salmonella enterica serovar 
Choleraesuis (SCR), serovar Typhimurium (STG), or sterile media (CTL).  Total RNA extracted 
at 14 d post initial challenge.  Each treatment bar represents the least square mean (± SEM) of 
eight observations. Bars without common superscripts denote significant differences (P < 0.05). 
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